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was first designed and tested with clinical hardware. MRI-derived PW was negatively correlated with high 
resolution peripheral quantitative computed tomography (HR-pQCT) derived BMD, while bone mineral 
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scanners, therefore requiring correction. Finally, the suggested protocol was applied in an ongoing 
osteoporosis treatment study. Expected observations –– elevated pore water, lowered bound water and 
phosphorus densities –– were observed in the patient group relative to healthy controls in limited 
baseline data acquired thus far. 
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a clinical setting, and may aid in better predicting osteoporotic fractures. 
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ABSTRACT 
MRI-BASED ASSESSMENT OF CORTICAL BONE MATRIX AND 
MINERAL PROPERTIES IN A CLINICAL SETTING 
Xia Zhao 
Felix W. Wehrli, Ph.D. 
Hee Kwon Song, Ph.D. 
As a pathological condition primarily afflicting the elderly, osteoporosis is becoming 
more prevalent with today’s lengthened life expectancy. Osteoporosis-associated 
fractures are dangerous, often associated with lethal complications, and impose a huge 
economic burden on society. Unfortunately, current techniques used to diagnose the 
disease cannot provide reliable fracture risk prediction, as they rely upon apparent bone 
mineral density (BMD) only. 
Recent advances in short echo time (TE) imaging have made it possible to examine 
different properties of bone with magnetic resonance imaging (MRI). Water bound to the 
collagen matrix (bound water, BW), water residing in the pore space (pore water, PW), 
and phosphorus (31P) in bone mineral crystals have previously been proposed as surrogate 
markers for bone matrix density, porosity and mineral density, to be quantitatively 
imaged with either 1H or 31P ultra-short TE (UTE) or zero TE (ZTE) sequence. 
In this dissertation, an integrated MRI protocol measuring both bone matrix and mineral 
properties in vivo was first designed and tested with clinical hardware. MRI-derived PW 
was negatively correlated with high resolution peripheral quantitative computed 
tomography (HR-pQCT) derived BMD, while bone mineral content based on MRI-
derived phosphorus density was positively correlated with that based on HR-pQCT 
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BMD. Second, in vivo bone phosphorus relaxation times were studied in a small cohort of 
healthy volunteers (aged 29 to 65). The relative invariability of relaxation properties 
obviated the need for individual measurements in this healthy cohort. Third, gradient 
imperfections were found to introduce errors in UTE image-based bone water 
quantification and to undermine measurement agreement across scanners, therefore 
requiring correction. Finally, the suggested protocol was applied in an ongoing 
osteoporosis treatment study. Expected observations –– elevated pore water, lowered 
bound water and phosphorus densities –– were observed in the patient group relative to 
healthy controls in limited baseline data acquired thus far. 
In conclusion, this dissertation proves the feasibility of measuring bone matrix and 
mineral surrogates in a clinical setting, and may aid in better predicting osteoporotic 
fractures. 
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CHAPTER 1: CORTICAL BONE PHYSIOLOGY AND 
PATHOLOGY 
1.1 Cortical Bone Anatomy and Physiology 
1.1.1 Macrostructure of Bone 
As major components of the musculoskeletal system, most bones are comprised of a 
trabecular (or spongy, or cancellous) portion and a cortical (or compact) portion (Figure 
1.1). Trabecular bone consists of trabeculae, in the shape of plates and rods organized in 
the direction of stress experienced by the bone, and is usually found on the inside of flat 
bones and at the ends of weight bearing bones. Cortical bone, on the other hand, forms 
the diaphysis of long bones and the exterior of other bones. The exact distribution and 
proportion of the two vary depending upon the overall function of the bone in question 
[1]. 
 
Figure 1.1 Photo showing the trabecular portion and cortical portion of a human femur at the 
metaphysis and epiphysis. 
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1.1.2 Microstructure of Cortical Bone 
Cortical bone is composed of smaller structural and functional units called osteon 
(Figure 1.2). Osteons are made of concentric layers of mineralized collagenous sheets 
(lamellae), forming the Haversian canal at the center. Haversian canals house the blood 
vessels, lymph vessels and nerves that supply the bone tissue. Running perpendicular to 
Haversian canals, are Volkmann’s canals, which connect osteons with each other and to 
the periosteum (exterior surface of cortical bone) and endosteum (interior surface of 
cortical bone). The many small holes interspersed within and between osteons are called 
lacunae. Lacunae accommodate osteocytes, a type of bone cell that develops from 
osteoblasts (bone forming cells, introduced in Section 1.1.4) trapped within the structure 
during the bone formation. The relationship between osteons, Haversian canals, and 
lacunae can be visualized in the microscopic image in Figure 1.3. Lacunae are connected 
to each other, and to the Harversian canal, via smaller canals termed canaliculi, 
constructing the lacuno-canalicular system. The lacuno-canalicular system nourishes 
osteocytes with nutrients and removes the metabolic wastes they produce. This system 
also allows for communication between osteocytes, believed to be the mechanism by 
which bone senses mechanical stimuli [2]. 
	
3	
 
Figure 1.2 Hierarchical structure of human cortical bone [3]. 
 
Figure 1.3 Microscopic image of human cortical bone [4]. Osteons are constructed from layers 
of lamella, forming the Haversian canal at the center. Lacunae are interspersed within and 
between osteons. 
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1.1.3 Composition of Bone Matrix 
The non-cellular portion of bone breaks down further into two major constituents, the 
organic phase (the bone matrix) –– mainly type I collagen, and the inorganic phase (often 
referred to as bone mineral) –– hydroxyapatite (HA). Collagen accounts for about 20% to 
40% of weight in adult bone while mineral accounts for another 50% to 70% [1]. The 
remaining mass is attributed to other substances such as cells and water (Figure 1.4). 
 
Figure 1.4 Anatomy of cortical bone matrix [5]. Three amino acids form a collagen molecule, 
by binding to each other via covalent bonds to create collagen fibril. Fibrils are subsequently 
organized into layers of lamella that construct individual osteons, the structural units of 
cortical bone. Mineral crystals are interspersed in the gaps between the collagen molecules to 
provide bone with rigidity. Water molecules bound to the matrix further reinforce the 
mechanical strength of this structure.  
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Figure 1.5 Structural hierarchy of collagen fiber [6]. Each collagen fibril consists of three 
amino acids intertwined with each other to form a triple helix. A collagen fiber is composed of 
a number of such fibrils. Collagen fibrils stack together in order to give the fiber its 
characteristic periodic spacing pattern under microscope. 
As the fundamental building block of the matrix, each collagen fibril is made up of three 
amino acids (Figure 1.5). The amino acids are intertwined into triple helix structures that 
are attached to each other via covalent bonds to form fibers, which are further organized 
into a regular pattern to construct the matrix (Figure 1.4). The mineral crystals embedded 
in the spaces between collagen fibrils (Figure 1.4) are composed of a crystalline complex 
of calcium and phosphate (Figure 1.6) and store approximately 99% of the calcium and 
80% of the phosphorus in the human body [7]. Collagen fiber provides bone with 
elasticity and flexibility while mineral crystal provides stiffness and rigidity [1]. In 
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addition, water molecules bound to the matrix contribute to the ductility and plasticity of 
bone [5]. Collectively, these structural components provide bone with its characteristic 
mechanical property. 
 
Figure 1.6 The major constituent of bone mineral is non-stoichiometric calcium apatite [6]. 
1.1.4 Bone Remodeling 
Rather than being quiescent, bone tissue undergoes constant remodeling to repair micro- 
fractures from daily activity and in response to external stimuli such as mechanical stress 
and impact [1]. Two types of bone cells are involved in this process, osteoblasts and 
osteoclasts. Remodeling begins with the osteoclast dissolving the old bone tissue (bone 
resorption), followed by osteoblasts laying down the new bone matrix (bone deposition). 
The newly deposited matrix subsequently undergoes a primary (~ several weeks) and a 
secondary (~ several months) mineralization process to reach full mechanical competence 
[8]. The resorption of old bone tissue and deposition of new bone tissue ordinarily exist at 
a dynamic equilibrium to maintain total bone volume. However, in osteoporosis, the rate 
	
7	
of resorption can exceed that of deposition, leading to net loss of bone tissue and physical 
fragility.  
1.2 Osteoporosis 
1.2.1 Symptoms, Causes, and High Risk Population 
Osteoporosis is a pathological condition characterized by loss of bone mass and 
compromised mechanical strength. Morphologically, it manifests as overall thinning of 
the cortex, trabecularization of the endosteal surface, and expansion of the pore system. 
Concurrently, increased turnover rate also results in less time for newly generated bone 
tissue to undergo proper secondary mineralization, As a consequence, a 
disproportionately large loss in strength results [9]. 
 
Figure 1.7 Cross section at the mid-shaft of the femur of an 84-year old female with advanced 
osteoporosis (right), compared to that of a healthy 17-year old female (left) [10]. 
A number of factors may contribute to osteoporosis, including genetic diseases, 
malnutrition, or hormonal abnormalities. Menopause, which typically occurs in women 
near the age of 50, causes depletion of estrogen, a hormone that suppresses osteoclastic 
activity while promoting osteoblastic activity [11]. This process breaks the subtle balance 
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between bone resorption and deposition, and eventually leads to a net loss of bone tissue. 
As such, women are more vulnerable to osteoporosis than are men [12].  
1.2.2 Morbidity, Mortality and Economic Impact 
Osteoporosis is a major health issue in the industrialized world. Since the disorder 
primarily afflicts the elderly, prevalence continues to grow in conjunction with increased 
life expectancy. Based on an overall 10.3% prevalence in 2010 in a population of 99 
million aged 50 years or older, 10.2 million Americans were estimated to have the 
disease [12]. Further, the population over 50 years of age and with low bone mass –– 
often the precursor of osteoporosis –– is projected to reach 120 million in less than ten 
years from today [13]. Major consequences of osteoporosis include fractures of the 
vertebrae, wrist, humerus, and hip. Among these, fractures of the hip, which often 
involve a break at the femoral neck, are particularly traumatic. For many elderly people, a 
hip fracture may be life threatening. A number of studies have reported a substantial 
increase in mortality in the years following a hip fracture [14-17]. Worldwide, more than 
200 million people were estimated to suffer from osteoporotic hip fractures [18]. In 
Europe and the United States, 30% of women are reported to be osteoporotic, while 40% 
of post-menopausal women and 30% of men are expected to experience an osteoporotic 
fracture during their lifetime [12, 19, 20]. The total cost of treatment was more than $19 
billion in 2005 with this number projected to increase by 50% in 20 years [21]. 
1.3 Current Clinical Diagnosis Modalities 
Currently, the standard diagnostic modality for osteoporosis is dual-energy x-ray 
absorptiometry (DXA). DXA relies on areal bone mineral density (BMD) at specific 
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anatomical locations, with the spine and hip being the most frequent exam sites. A BMD 
T-score equal to or lower than -2.5 is regarded as clinically indicative for osteoporosis 
[22]. However, this technique has several limitations. First, its inability to discern 
between bone tissue and pore space prevents it from reflecting the extent of porosity or 
the true degree of mineralization of bone (DMB) –– mass of mineral per unit volume of 
matrix. Second, the two-dimensional (2D) projection nature of DXA subjects results of 
the exam to bias from bone size. Further, bone strength is a comprehensive outcome of a 
number of factors of which BMD is just one. So it is not surprising that DXA has a low 
fracture risk prediction accuracy –– only 44% of non-vertebral fractures were found to 
occur in women categorized as osteoporotic by DXA [23]. In addition, the density-based 
DXA may also mistake osteoporosis for demineralizing disorders, which have completely 
different pathologies and require different treatment plans. Peripheral quantitative 
computed tomography (pQCT) is a technique that reports volumetric BMD based on 
three-dimensional (3D) projection images.  The result is therefore not affected by bone 
shape and size [24]. The technique does visualize porosity to some extent although its 
power is limited to large pores only. Moreover, the increased amount of ionizing 
radiation patients are exposed to makes it unfavorable for repeated use in monitoring 
treatment response. Finally, although bone biopsy can determine both porosity and 
mineralization, it is not suitable for repeated use either due to the inherent invasiveness. 
Therefore, a technique able to accurately and non-invasively evaluate both the matrix and 
mineral phases of bone in vivo would be highly desirable. 
The non-invasive nature and multi-nuclei imaging ability of magnetic resonance imaging 
(MRI) renders it a potential alternative. It has been shown that surrogates of bone 
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porosity [25, 26] and matrix density [27-30] can be quantitatively evaluated in vivo with 
solid-state 1H MRI, while quantification of bone mineral using solid-state 31P MRI has 
been shown in animal models [31-33] and human specimens [28]. The ratio between 
MRI-derived phosphorus and the matrix surrogate could even provide an indirect 
measure of true mineralization. Information on these different aspects of bone property 
might potentially lead to more reliable prediction of osteoporotic fracture risk. 
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 CHAPTER 2: INTERROGATION OF BONE WITH 
MAGNETIC RESONANCE IMAGING 
2.1 Magnetic Resonance Imaging of Bone 
2.1.1 Principle of MRI 
An MRI experiment begins by placing the object being imaged inside the scanner’s main 
magnet, where the strong magnetic field (B0) aligns nuclear moments of individual nuclei 
to form bulk magnetizations [34]. A radio frequency magnetic field (RF pulse, often 
referred to as B1) oscillating at the Larmor frequency of the target nucleus (most 
commonly 1H in clinical applications) is applied, perpendicular to the main magnetic 
field, to flip part of the magnetizations into transverse plane (excitation) such that they 
rotate about the main field. Such rotation induces an alternating current electric signal in 
the receiving coils, as governed by Faraday’s law. In order to identify spatial locations of 
these nuclei, a set of gradient fields (encoding gradient) are superimposed on the main 
magnetic field to vary its strength in a spatially dependent manner. As a result, 
magnetizations from different locations precess at different frequencies, which is 
reflected in the frequencies and phases of the signal they produce. The electric signal 
induced in the receiving coils is subsequently digitized and collected through an analog to 
digital converter (ADC), forming the MRI raw data known as k-space. This entire 
sequence of hardware events, including application of the RF pulse, encoding gradients 
and the ADC, is termed a pulse sequence. A typical 3D Cartesian MRI sequence diagram 
is shown in Figure 2.1. Mathematically, the spatial distribution of nuclear spins within 
the imaged object and k-space are associated by Fourier transform, as illustrated in 
Figure 2. 2.  
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Figure 2.1 Diagram of a typical 3D Cartesian MRI sequence. Magnetizations are first excited 
by the RF pulse into transverse plane, where they rotate at spatially varying frequencies 
determined by encoding gradients (Gx, Gy and Gz) to produce signals with characteristic 
frequencies and phases, which are subsequently collected following digitization (ADC). 
 
Figure 2.2 a) k-Space and b) MRI image are reciprocal spaces associated by the Fourier 
transform.  
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2.1.2 Time Constant T1, T2 and T2* 
The flipping of bulk magnetization by an RF pulse is equivalent to decomposing it into 
two orthogonal components: one perpendicular to and rotating about the main magnetic 
field (transverse magnetization) to create the MRI signal, the other remaining parallel to 
the main field (longitudinal magnetization). The exact amount of each component is 
dependent upon the flip angle (FA). Longitudinal magnetization tends to recover back to 
its original magnitude exponentially at a rate determined by time constant T1 
(longitudinal relaxation time), the time it takes for longitudinal magnetization to recover 
from zero to 63% of its original length (Figure 2.3) [35]. The transverse magnetization 
tends to decay away exponentially with time constant T2 (transverse relaxation time), the 
time it takes for the transverse magnetization to reduce to 37% of its original value 
(Figure 2.4) [35]. The recovery of longitudinal magnetization and decay of transverse 
magnetization are termed longitudinal (or T1) relaxation and transverse (or T2) relaxation 
respectively. Table 2.1 summarizes typical T1 and T2 values measured at 1.5 T and 3 T 
field strengths. T2 relaxation occurs as a resultant loss of phase coherence (or dephasing) 
of spins within the system. In reality, however, the signal lifetime is significantly shorter 
than T2 predicts because of factors such as main field inhomogeneity and susceptibility-
induced local field distortion, [36], and is thus described by a more aggressive T2* 
(effective transverse relaxation time) exponential decay as shown in Figure 2.4. The time 
from RF excitation to the collection of an echo is defined as echo time (TE), which is 
typically on the order of milliseconds in clinical MRI systems. A k-space is composed of 
multiple echoes as demonstrated in Figure 2.2, where each echo is represented by an 
arrow. Since the MRI signal progressively attenuates following excitation due to T2 or 
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T2* decay, the k-space is usually filled in with multiple excitations-acquisition cycles 
instead of all at once. The interval between two successive excitations is called repetition 
time (TR). 
 
Figure 2.3 Illustration of T1 relaxation [37]. Here, the entire magnetization is flipped into 
transverse plane by a 90° RF pulse, leaving no residual longitudinal magnetization at the end 
of the excitation. The longitudinal magnetization then recovers back to equilibrium value 
exponentially. The speed of the recovery process is determined by time constant T1.  
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Figure 2.4 Illustration of T2 and T2* relaxation [37]. Immediately after being flipped into 
transverse plane by a 90° RF pulse, the transverse magnetization starts to decay as the 
constituent spins lose coherence, resulting in T2 relaxation. Due to factors like field 
inhomogeneity and susceptibility- induced local field distortion, spins lose phase coherence 
more rapidly, leading to a more aggressive T2* relaxation. 
Table 2.1 T1 and T2 relaxation times of various human tissues measured at 1.5 T and 3 T [38]. 
Tissue T2 – 1.5 T (ms) T1 – 1.5 T (ms) T2 – 3 T (ms) T1 – 3 T (ms) 
Liver 46 ± 6 576 ± 30 42 ± 3 812 ± 64 
Skeletal Muscle 44 ± 6 1008 ± 20 50 ± 4 1412 ± 13 
Heart 40 ± 6 1030 ± 34 47 ± 11 1471 ± 31 
Kidney 55 ± 3 690 ± 30 56 ± 4 1194 ± 27 
White Matter 72 ± 4 884 ± 50 69 ± 3 1084 ± 45 
Gray Matter 95 ± 8 1124 ± 50 99 ± 7 1820 ± 114 
Optic Nerve 77 ± 9 815 ± 30 78 ± 5 1083 ± 39 
Spinal Cord 74 ± 6 745 ± 37 78 ± 2 993 ± 47 
Blood 290 ± 30 1441 ± 120 275 ± 50 1932 ± 85 
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2.1.3 Surrogates for Bone Matrix and Mineral 
Bone has very unfavorable relaxation properties compared to most human tissues. As 
illustrated by the proton (1H) T2 spectrum in Figure 2.5, three distinct pools of 1H are 
readily identified: 50 µs < T2 < 150 µs, corresponding to the collagen matrix itself; 150 
µs < T2 < 1 ms, corresponding to the water molecules bound to the collagen matrix 
(bound water, BW); and finally 1 ms < T2 < 1 s, corresponding to the water molecules 
freely residing in the pore space (Haversian canal, Volkmann’s canal and lacuno-
canalicular system) within the matrix (pore water, PW). The bone matrix’s extremely 
short T2 is due to restricted molecular motion in the well-organized collagen structure, 
making it less efficient to average out the effect of local field inhomogeneity, and 
resulting in faster dephasing between spins and a consequent decay of transverse 
magnetization. Compared to the 1H on collagen fiber, bound water has a certain degree of 
molecular motion that allows for a slightly longer T2. Pore water has even more freedom 
of motion and therefore has the longest T2 among the three. However, these values are 
still one to three orders of magnitude smaller than the T2 of other tissues in human body 
(Table 2. 1) and are much shorter than the TE of clinical sequences. As a result, bone 
tissue always appears dark on conventional MRI images. Although directly capturing 
signal from bone matrix itself is restricted by hardware limitations of clinical MRI 
systems, the bound and pore water can be detected with special techniques. Earlier 
studies have demonstrated successful capture of the two water pools and their potential to 
serve as surrogates for matrix density and porosity of bone tissue, respectively [39, 40].  
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Figure 2.5 Averaged proton T2 spectrum obtained from 40 human cortical bone samples [39]. 
Being a major component of bone mineral crystal (Figure 1.4) and directly proportional 
to the total amount of bone mineral content, the phosphorus nucleus (31P) is also MR 
sensitive. In spite of having relaxation times even less favorable than bone water [41, 42], 
a number of studies have explored the feasibility of interrogating bone mineral via 31P 
MRI [27, 31-33, 42-44]. 
2.2 Solid State MRI Techniques 
Even though bone water and phosphorus are beyond the capability of conventional MRI 
techniques due to their extremely short transverse relaxation times, specially designed 
imaging sequences featuring extraordinarily short TE (solid-state imaging sequence) can 
be utilized. A couple of solid-state MRI techniques have been developed in response to 
challenges posed by species with extremely short effective transverse relaxation time. 
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2.2.1 Ultra-short Echo Time Imaging (UTE) 
One such technique is ultra-short echo time (UTE) imaging [45]. In a typical UTE 
experiment (Figure 2.6a), the encoding gradient is switched on immediately after the 
transmit/receive dead time, and data acquisition is initiated on the ramp-up stage of the 
gradient. Each excitation and readout results in a half projection within the k-space. The 
orientation of the encoding gradient is altered from one TR to the next to cover the entire 
k-space (Figure 2.7a). As a result of ramp sampling, where the gradient is not at full 
strength, and k-space is traversed more slowly (but at an accelerating speed) as compared 
to when the gradient is fully ramped up, the center of k-space is more densely sampled as 
compared to the outer k-space.  
 
Figure 2.6 Sequence diagrams of a) UTE and b) ZTE. 
A UTE sequence is characterized by the following features: first, with effective echo time 
limited only by the hardware’s transmit/receive switch time (or receiver dead time), UTE 
is able to visualize spins with T2* as short as a few hundred microseconds [45, 46]; 
second, the image is less prone to susceptibility artifacts due to the short TE.  
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Figure 2.7 k-Space of a) UTE and b) ZTE-PETRA sequence. In UTE, k-space encoding starts 
during the ramp-up stage of the gradient. Therefore, sampling density is higher near the k-
space center than in the outer region where the gradient reaches full strength. Encoding 
direction is altered from one TR to the next to cover the entire k-space. In ZTE, on the other 
hand, the gradient is fully ramped up prior to RF excitation, resulting in k-space data missing 
around the center due to the transmit/receive switch. In the case of ZTE-PETRA, the missing 
data points are recovered via single point imaging on a Cartesian grid through a second 
acquisition. 
2.2.2 Zero Echo Time Imaging (ZTE) 
Another powerful short-T2 visualization technique is zero echo time (ZTE) imaging 
(Figure 2.6b). In contrast to UTE, the encoding gradient is fully ramped up prior to the 
RF pulse in ZTE, and data are collected immediately following the transmit/receive dead 
time. Since the gradient is always on, k-space encoding starts instantaneously after 
excitation (hence the name ‘zero’ echo time) and the data points encoded during dead 
time are lost. The missing data points are recovered via a second set of scans, where the 
inner k-space is filled either by FIDs acquired with lower bandwidth, as the SMRI [47] 
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used in WASPI [48], or with single point encoded with an incrementally-stepped gradient 
as in PETRA [49]. As shown in Figure 2.7b, a ZTE (PETRA in this case) k-space 
consists of two distinct regions. The peripheral portion corresponds to the initial radial 
acquisition, while the central portion corresponds to the second acquisition acquired on a 
Cartesian grid. 
Although the effective echo time of ZTE is also determined by the hardware, as in UTE, 
the center portion of k-space is traversed faster because the encoding gradient is already 
at full strength. Further, the PETRA acquisition allows the data points near k-space center 
to be acquired at the same effective echo time. Therefore, ZTE images possess higher 
signal-to-noise ratio (SNR) and are less prone to blurring than UTE images. 
One inherent drawback of ZTE is the presence of encoding gradient during excitation, 
which renders the RF pulse spatially selective. The varying excitation profile from k- 
space line to k-space line can result in undesirable shading artifacts and blurring 
throughout the reconstructed image. Since the frequency response of a RF pulse could be 
approximated by the Fourier transform of the pulse shape in the low flip-angle regime 
[50], the wider the pulse, the heavier the signal modulation. As well, restrictions on the 
specific absorption ratio (SAR) limit the peak B1 power of the RF pulse. As a result, ZTE 
is restricted to low FA applications in humans. 
2.2.3 UTE and ZTE Image Reconstruction 
For MR data acquired in Cartesian k-space (as is the case for most clinical MRI 
sequences), images can be reconstructed via direct fast Fourier transform (FFT). For 
sequences acquiring data in non-Cartesian k-space such as UTE and ZTE, direct 
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application of FFT will not work. Instead, the radially collected data points must be first 
re-gridded onto a Cartesian coordinate. The re-gridded points are essentially the weighted 
sum of the neighboring original data. However, the varied distance of each raw data point 
to a specific point on the Cartesian grid determines they may not necessarily have the 
same contribution in this process. For instance, in Figure 2.7, the sampling pattern is 
generally denser in the inner k-space than in the outer. Therefore, a faithful image 
reconstruction relies on proper weight (or sampling density) compensation of the raw 
data [51]. Following the re-gridding procedure, the image is generated with FFT as in 
conventional MRI. 
2.3 Separation of Different Bone Water Pools 
2.3.1 Bone water separation techniques 
In addition to capturing bone water signals, the ability to distinguish between water pools 
is equally important, as they are biomarkers for different characteristics of bone. A 
number of T2*- and T2-based techniques have been proposed for this purpose. Dual-echo 
subtraction is the simplest and most straightforward T2*-based method, in which two 
echoes (one at a short, the other at a longer TE) are acquired following each excitation. 
While the first echo contains signals from both short- and long-T2* components, only the 
long-lived signal persists in the second echo [45, 52]. Therefore, short-T2* BW could be 
established by subtracting echo two from echo one. However, this is not an ideal method 
to suppress long-T2* species since remnants of PW remain in the resulting image. A 
second T2*-based technique is bi-exponential fitting, whereby images are acquired at 
multiple TEs and fitted to a bi-exponential decay model to extract the relative proportions 
of the two water pools [30, 53]. Unfortunately, this method is neither time efficient nor 
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robust across various field strengths [54]. Another problem associated with T2*-based 
techniques is their difficulty differentiating BW from water in smaller pores, given their 
similar T2*, which is not as much an issue for T2-based methodologies. One T2-based 
method is dual-band saturation preparation, where a long pulse with two spectral 
saturation bands (at water and fat resonances, respectively) is applied prior to readout. 
Although effective at isolating short-T2 BW, its effectiveness may be compromised by 
spatial variations in either the B0 or B1 field. Another commonly used long-T2 
suppression technique is adiabatic inversion recovery (IR) [55]. An adiabatic (hyperbolic 
secant, for example) is first applied to selectively invert the long-T2 spins while the short-
T2 spins are merely saturated due to their fast transverse relaxation during the pulse. This 
is followed by conventional short TE readouts at the nulling time of the long-T2 spins, 
leaving only short-T2 spins detected. 
2.3.2 Adiabatic Inversion 
Adiabatic inversion recovery is based on a phenomenon called adiabatic following. From 
the perspective of the rotating frame (the coordinate system rotating about the z axis at 
the Larmor frequency), the B1 is the only magnetic field present when the RF pulse is 
applied on resonance. On the other hand, applying the pulse with a frequency offset (Δω) 
is equivalent to having a residual z component of magnetic field in addition to B1. Instead 
of rotating about the B1, the magnetization will rotate about an effective field (Beff), 
which is the vector sum of the applied B1 and the residual longitudinal field. According to 
Figure 2.8, the angle between Beff and the z-axis of the rotating frame is determined by 
the amount of offset-frequency. In other words, the orientation of Beff could be 
manipulated by adjusting the frequency of the RF pulse. As long as the adiabatic 
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condition described in Equation 2.1 is satisfied, magnetization will follow the path of 
Beff (hence the name ‘adiabatic following’). To achieve adiabatic inversion, the frequency 
of the RF pulse is ‘swept’ from one side of the Larmor frequency to the other. As a result, 
magnetization is rotated from z-direction to –z direction by following the effective field. 
                                                           𝑑𝛼 𝑑𝑡 ≪ 𝛾𝐵!""                                        [2.1] 
 
Figure 2.8 Vector diagram showing the effective field and its components. The thin black 
coordinate system (x’, y’ and z’) is the rotating frame, while the thick gray coordinate system 
(x’’, y’’ and z’’) is the frame for effective field [55]. 
The advantages of adiabatic IR include a narrow transition band (Figure 2.9) in 
frequency response and relative immunity to B1 inhomogeneity and frequency offset. 
According to Li et al., the adiabatic inversion recovery-based technique achieves the best 
short-T2 contrast [46].  
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Figure 2.9 Response of magnetizations from different water pools to adiabatic inversion pulse 
as a function of T2 [40]. 
2.4 Focus of This Dissertation: Cortical Bone 
Over the past several decades, clinical investigations have focused on trabecular bone for 
two reasons [56-59]. First, most fracture sites are dominated by trabecular bone. Second, 
the faster remodeling rate of trabecular bone makes it a more convenient target than 
cortical bone to study the effectiveness of clinical intervention [60-64]. However, 80% of 
the skeletal system’s mass consists of cortical bone. Although occurring at a lower rate, 
cortical bone also undergoes remodeling and major alteration due to aging or hormone 
depletion in women following menopause. The notion that stress is shared between 
cortical and trabecular bone at frequent fracture sites, such as the femoral neck, 
necessitates a better understanding of cortical bone as well. Therefore, the proposed 
project is fully dedicated to studying cortical bone. 
2.5 Chapter Outline 
This dissertation aims to explore the issues involved in establishing a protocol for MRI- 
based bone matrix and mineral examination in a clinical setting. In Chapter 3, the 
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feasibility of translating bone matrix and mineral quantification techniques previously 
developed and validated with animal and ex vivo experiments, to an in vivo application, is 
investigated. Chapter 4 evaluates the in vivo values and inter-subject variation of bone 
31P relaxation times as well as their implication on bone mineral quantification. Chapter 
5 is dedicated to the impact of hardware imperfections on UTE image quality and image- 
based bone water quantification. Chapter 6 presents an ongoing osteoporosis patient 
study that makes use of the techniques described in earlier chapters as well as some 
preliminary results. Major accomplishments of this dissertation and potential future 
works are summarized in Chapter 7.  
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CHAPTER 3: FEASIBILITY OF ASSESSING BONE 
MATRIX AND MINERAL PROPERTIES IN VIVO BY 
COMBINED SOLID-STATE 1 H AND 31P MRI 
3.1 Abstract 
Purpose: To develop and evaluate an integrated imaging protocol for bone water and 
phosphorus quantification in vivo by solid-state 1H and 31P MRI. 
Methods: All studies were health insurance portability and accountability act (HIPAA)-
compliant and were performed with institutional review board approval and written 
informed consent. 1H UTE and 31P ZTE sequences were designed and implemented on a 
3 T clinical MR scanner to quantify bone water and mineral in vivo. The left tibia of ten 
healthy subjects (including both genders, 49±15 y/o) was examined with a custom-built 
1H/31P dual-frequency extremity RF coil. Total bone water (TW), water bound to the 
collagen matrix and bone phosphorus were quantified from MR images with respect to 
reference samples of known 1H or 31P concentration, and pore water was subsequently 
determined from total water and bound water. Porosity index (PI) was calculated as the 
ratio between UTE images acquired at two echo times. MRI parameters were compared 
with bone density measures obtained by high-resolution peripheral quantitative CT (HR-
pQCT). 
Results: The total scan time for the bone water and phosphorus quantification protocol 
was about 50 minutes. Average TW, BW, PW and 31P concentrations were 13.99 ± 1.26, 
10.39 ± 0.80, 3.34 ± 1.41 mol/L and 5.29 ± 1.15 mol/L for the studied cohort, 
respectively, in good agreement with previous results conducted ex vivo. Average intra-
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subject coefficients of variation were 3.47%, 2.60% and 7.50% for TW, BW and PW and 
5.60% for 31P. Negative correlations were observed between PW and vBMD (p < 0.05) as 
well as between PI and 31P (p < 0.05), while bone mineral content (BMC) estimated from 
31P MRI and HR-pQCT were strongly positively correlated (p < 0.0001). 
Conclusion: This work demonstrates the feasibility of quantifying bone water and 
mineral phosphorus in human subjects in a single MRI session with a clinically practical 
imaging protocol. 
3.2 Introduction 
Cortical bone, which accounts for 80% of the skeleton by weight, consists of an organic 
substrate (also referred to as matrix) composed predominantly of type I collagen, 
interspersed with mineral crystals of non-stoichiometric calcium apatite. Blood supply 
occurs through a system of interconnected pores (Haversian and Volkmann canals). In 
osteoporosis, an increasingly prevalent condition afflicting the older population [12, 65], 
thinning of the cortical shell occurs, along with pore expansion and depletion of mineral 
and matrix, thereby compromising the bone’s mechanical competence [66]. 
The current standard modality for osteoporotic fracture risk assessment is DXA, which 
measures gross density of bone material and, thus, cannot provide information on 
microstructure (such as cortical pore volume fraction and pore size distribution) or tissue 
mineralization. Consequently, DXA has low predictive accuracy — only 44% of non- 
vertebral fractures were found to occur in women with DXA-reported T-scores below -
2.5 [23]. Similarly, DXA is unable to distinguish osteomalacia, a disorder in which bone 
is poorly mineralized but the pore volume fraction remains largely unchanged [67], from 
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osteoporosis, where pore volume fraction increases but the remaining bone is normally 
mineralized. 
Risk assessment has recently been augmented with the fracture risk assessment tool 
(FRAX) [68]. However, alternative techniques that can directly evaluate bone matrix, 
pore space, and mineralization in vivo are needed to provide more complete insight into 
the determinants of the bone’s mechanical competence. 
Intra-cortical remodeling during aging, and more so in osteoporosis, involves expansion 
of pores [69]. Although most pores are beyond the resolution limit of in vivo imaging 
modalities, the portion of total bone water residing in the pore space scales inversely with 
matrix density [28] and has been shown to be quantifiable by MRI. On the other hand, 
although collagen protons themselves are not visible with clinical imaging equipment 
owing to their extremely short T2 (tens of microseconds), water bound to collagen scales 
linearly with bone matrix density. It has been shown that these two water pools can be 
distinguished from one another given their very different T2 [70] or T2 relaxation times 
[53]. Ex vivo studies have demonstrated quantification of pore and bound water based on 
MR images of human cortical bone [27, 28], as well as the correlation between these 
water pools and bone mechanical strength [39, 71, 72]. Techawiboonwong et al. first 
quantified total bone water in the tibial cortex in vivo [73], while separation of the two 
water pools (BW and PW) in vivo has recently been reported by Manhard et al. using T2- 
selective imaging sequences [29] and, more recently, by Chen et al. using bi-exponential 
fitting of the T2 signal decay [30]. 
Quantitative MRI of 31P would potentially provide complementary insight into bone 
	
29	
mineral properties. Animal studies have shown that 31P MRI-based quantification is able 
to detect impaired mineralization density in hypophosphatemia-induced osteomalacia in a 
rabbit model, as well as effects of anti-resorptive treatment in ovariectomized rats at 9.4 
T [31-33]. The feasibility of in vivo 31P imaging in human subjects was shown first at 1.5 
T [44] and, more recently at 3 T [42], albeit without quantification of 31P. Seifert et al. 
measured phosphorus density by 31P solid-state MRI of human cortical bone of the tibia 
ex vivo at 7 T using custom-designed RF coil and pulse sequences [27]. However, there 
have so far been no reports on quantification of 31P density by in vivo human MRI. 
The current work aims to demonstrate the feasibility of combined MRI-based in vivo 
bone water and mineral quantification, including discrimination of bound and pore water, 
as part of a single integrated imaging protocol.  
 
Figure 3.1 In vivo experiment set up. The experiment was performed on a Siemens 3 T Trio 
system with a Rapid 1H/31P dual-frequency birdcage calf coil. 
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3.3 Materials and Methods 
3.3.1 Human Subjects 
31P ZTE’s capability of detecting the 31P signal in the tibial shaft was initially evaluated 
on a 32-year old male in the presence of hydroxyapatite samples with 31P concentrations 
distributed in a wider range (3–7.5 mol/L). Subsequently, the entire protocol was 
executed in a cohort of healthy subjects. Inclusion criteria for enrollment were: 1) no 
medical history of diseases or treatments known to affect bone mineral homeostasis (e.g. 
mal-absorption syndromes, renal or hepatic disease, treatment with dexamethasone or 
methotrexate); 2) no conditions limiting normal physical activity (e.g. stroke, hip or leg 
fracture, rheumatoid arthritis); 3) body mass index < 30 kg/m2. All in vivo studies were 
done in compliance with health insurance portability and accountability act (HIPAA) 
regulations, and were approved by the University of Pennsylvania’s institutional review 
board (IRB) under protocol #823377. All subjects provided written informed consent. 
Ten healthy volunteers (two males, eight females, age range: 29 to 65 y/o, mean (SD) = 
49 (15) y/o), recruited from the University of Pennsylvania (Philadelphia, PA), from July 
to August of 2016, participated in this study. 
3.3.2 Imaging Protocol 
MRI scans were performed on a 3 T TIM Trio system (Siemens Medical Solutions, 
Erlangen, Germany) using a custom-built transmit/receive 1H (123 MHz)-31P (49.9 MHz) 
dual-tuned birdcage coil (Rapid Biomedical, Rimpar, Germany). The hardware setup is 
shown in Figure 3.1. The complete protocol including localizer scans, 31P transmit power 
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calibration and three radial imaging scans for quantification of bone water and 
phosphorus lasted approximately 50 minutes. The radial scans consisted of two 1H UTE 
sequences for quantification of TW and BW (from which PW was indirectly determined) 
and one 31P ZTE sequence for measuring bone phosphorus content. Details are given in 
the sub-sections below. All scans were carried out in the presence of a 1H density 
calibration sample (20% H2O/80% D2O, doped with 27 mmol/L of MnCl2, corresponding 
to a H2O concentration of 11 mol/L, T1 = 4.3 ms, T2 = 320 µs) and two 31P density 
calibration samples (one consisting of a mixture of hydroxyapatite and calcium sulfate 
powders, [31P] = 7.5 mol/L, T1 = 46.2 s, T2 = 139 µs; and one consisting of pure 
hydroxyapatite powder, [31P] = 9.5 mol/L, T1 = 42.2 s, T2 = 145 µs), positioned in close 
proximity and directly anterior to the section of tibia being examined. This MRI 
procedure was applied in ten subjects, and was repeated an additional two times in a 
subset of three subjects to evaluate test-retest repeatability. Each of these three subjects 
dismounted the table and was repositioned between successive repetitions on the same 
day, or was scanned on a different day within a three-week period. MRI scans were 
centered at 38% tibia (38% of the tibia length from the medial malleolus), where the 
cortical bone is thickest [27]. HR-pQCT was also performed for comparison with 31P 
results. 
1H dual-echo UTE 
Total water was imaged using a 3D 1H dual-echo UTE sequence [46] (Figure 3.2a). An 
80 µs rectangular RF pulse was used for excitation, and two ‘echoes’, were sampled at 50 
µs (TE1) and 4.6 ms (TE2) after the RF pulse. The prescribed field of view (FOV) was 
(250 mm)3, TR was 10 ms, and FA was 16°. Fifty thousand radial spokes, distributed to 
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fully sample the spherical k-space, were collected at a dwell time of 4 µs in 8.3 min. The 
duration of the gradient ramp was 240 µs, and 158 points were acquired along each radial 
spoke to populate an image matrix of 256x256x256. Images were reconstructed at an 
isotropic voxel size of (0.98 mm)3.  
 
Figure 3.2 Diagrams of UTE and ZTE radial imaging sequences. a) 1H dual-echo UTE and b) 
1H IR_rUTE sequences for bone water quantification and porosity evaluation. In (a), two FIDs 
were collected following each excitation, at TE1 = 50 µs and TE2 = 4.6 ms. Spins were 
rewound after collecting the first FID but spoiled after the second. In (b), an HS pulse was 
applied to specifically invert long-T2 spins while saturating short-T2 spins, followed by an 
inversion time TI to null long-T2 spins, and seven UTE readouts. c) 31P ZTE to quantify bone 
31P concentration. Readout gradients are switched on prior to the RF pulse to ensure k-space is 
traversed with full speed following excitation. 
1H IR-rUTE 
Bound water was isolated and imaged using a 3D 1H IR-prepared rapid UTE (IR-rUTE) 
sequence [46, 74] (Figure 3.2b), which takes advantage of the differences in both T1 and 
T2 of bound and pore water. Due to its T2-selectivity, the adiabatic inversion pulse at the 
beginning of each TR inverts the long-T2 pore water magnetization while only saturating 
the short-T2 bound water spins [27]. After an appropriately chosen inversion recovery 
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delay (TI), at which time the longitudinal magnetization of pore water spins reaches zero 
while that of bound water has recovered to a positive value, a series of seven spokes were 
acquired [74]. Thus only bound water signal is detected within cortical bone. In the 
current implementation, adiabatic inversion was realized by a 5-ms, 5-kHz hyperbolic 
secant (HS) pulse, TI was set to 65 ms, and repetition time between consecutive 
inversions was 194 ms. Each of the seven UTE readouts was initiated by an 80 µs 
rectangular pulse, with flip angles increasing from 23° to 40° (variable flip angle scheme, 
VFA [74]) to create constant transverse magnetization from a diminishing reserve of 
longitudinal magnetization. The separation between each UTE readout was 2 ms. Twelve 
thousand spokes were collected at an effective TE of 50 µs resulting in 5.8 min total scan 
time. FOV, dwell time, number of points, and voxel size were the same as for dual-echo 
UTE. 
31P ZTE 
Mineral phosphorus was imaged with the ZTE-PETRA technique [49] in lieu of the UTE 
strategy (Figure 3.2c). ZTE allows for faster k-space traversal, as no ramp sampling is 
involved. Therefore, given the extremely short T2 (< 200 µs [42]), ZTE has been found to 
have superior SNR relative to UTE under similar sequence parameter settings [41]. 
Although the first several ZTE readout points are lost during the transmit/receive 
switching time, the PETRA technique recovers the lost data within this sphere via single 
point imaging (SPI, all at the same effective TE) — mitigating point spread function 
blurring of the image due to T2 exponential modulation of the k-space. 31P ZTE-PETRA 
was optimized for the experimentally observed relaxation parameters. TR and FA were 
150 ms and 6.5°, rectangular RF pulse width was 16 µs, and 8000 spokes were sampled 
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at a dwell time of 8 µs. PETRA radius (equal to the number of readout samples lost 
during transmit/receive switching time) was set to 6 (hence, the effective TE was dwell 
time × PETRA radius = 48 µs), for a total of 895 single points [49]. FOV was matched to 
that of the two 1H UTE sequences, but only 50 points along each spoke were acquired for 
reconstruction, leading to a reconstructed voxel size of (2.5 mm)3. Total scan time was 
22.5 min. Since the scanner’s transmit power auto-calibration was not operational for 
nuclei other than 1H, the flip angle was calibrated for every subject prior to the 31P ZTE 
scan by incrementally stepping the power and maximizing the equilibrium calf muscle 
phosphocreatine signal. 
HR-pQCT 
HR-pQCT scans were performed on an XtremeCT II system (Scanco Medical, 
Brüttisellen, Switzerland). X-ray tube was operating at voltage/current of 68 kVp/1.47 
mA. A 140×140×10.2 mm3 volume was imaged and reconstructed to a 2304×2304×168 
matrix size, resulting in an isotropic spatial resolution of (61 µm)3. Only nine of the 
subjects received this scan because the scanner was unable to accommodate the limb size 
of one of the subjects. 
3.3.3 Quantification 
Images were reconstructed by re-gridding to Cartesian k-space and standard Fourier 
transform [49]. Cortical water concentrations were determined from 1H images by 
referencing the signal within the tibial cortex to that of the MnCl2 doped calibration 
sample, and 31P concentrations were calculated similarly by referencing the tibial signal 
against that of the hydroxyapatite samples. Details on conversion of signal intensities to 
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concentration are given in the following sections. Both image reconstruction and 
quantification were performed with custom programs written in MATLAB (Mathworks, 
Natick, USA). 
Bone water quantification 
Total water was quantified from the central 45 slices (corresponding to a 44.1-mm thick 
slab) of the first echo image of the dual-echo UTE scan. Regions of interest (ROI) for 
cortical bone and calibration sample were drawn for each of these slices using a semi-
automated segmentation algorithm [75]. The average intensity within the ROI of the 
calibration sample was used to compute the total water concentration within the cortical 
bone region on a pixel-by-pixel basis based on Equation 3.1:  
                                        𝜌!"#$ = 𝜌!"#
!!"#$!!"#
!!"#!!"#$
𝑒
!!" !!!_!"#
∗ !
!
!!_!"#$
∗
                      [3.1] 
where ρref and ρbone are 
1H densities in reference sample and cortical bone respectively, 
Iref and Ibone are image intensities, while Fref and Fbone represent the fractions of 
magnetization available for signal detection (see Appendix).  
We note that even though T1 values of bone water and calibration samples differ, 
absolute concentrations can be computed from Equation 3.1 since we know the chemical 
makeup, concentration and T1 of the calibration sample. The same arguments also apply 
to quantification of 31P mineral density below. Bound water maps were generated in the 
same way from the IR-rUTE images using the same ROIs based on Equation 3.1, but 
with Fref and Fbone replaced by IR_Fref and IR_Fbone respectively, which represent 
fractions of magnetization detected in IR-rUTE sequence (Appendix). Subtraction of the 
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Bound water from the total water maps yielded a parametric image of pore water. Median 
values were then used for statistical analysis. The following population average values 
for total and bound water relaxation times were used for bone water signal correction: 
T1_total = 250 ms, T2_total = 750 µs [75], T1_bound = 145 ms, T2_bound = 390 µs [54]. The ratio 
between the two images of dual-echo UTE sequence within the tibial cortex, referred to 
as porosity index [26], was also computed in a pixel-wise manner. 
Bone phosphorus quantification 
Due to the inherently lower SNR of 31P images, 31P concentration was quantified based 
on total signal within the volume of interest. To obtain the total 31P signal 18 consecutive 
axial images (corresponding to the same volume over which bone water was evaluated) 
were first complex-summed along the slice direction to produce an axial projection image 
with adequate SNR to clearly delineate the tibia and calibration sample boundaries. An 
ROI fully encompassing the tibia was then selected. Then a second complex summation 
was performed for pixels within this ROI, resulting in a single value whose magnitude 
represents total 31P signal. Signal from the reference samples was obtained in the same 
manner. Next, the actual volume of the tibial cortex was measured from the ROIs drawn 
for bone water quantification, whereas the volume of the HA sample was manually 
calculated using the inner diameter of the tubes. Volumetric average signal intensities of 
cortical bone and HA samples were subsequently determined, and after accounting for T1 
and T2 differences, tibial 31P concentration was estimated via Equation 3.1. Population 
averages of T1 = 18 s and T2 = 160 µs were taken for bone 31P relaxation correction [42]. 
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3.3.4 Statistical Analyses 
Intra-subject coefficient of variation was calculated for all MRI-derived parameters for 
the three test-retest subjects. MRI-derived quantities were also compared with HR-pQCT 
reported volumetric bone mineral density (vBMD), and correlations among all 
parameters were determined. In addition, sub-region analysis was conducted by dividing 
the analysis slab into anterior, posterior, medial and lateral quadrants to determine 
possible regional differences in the measured parameters using analysis of variance 
(ANOVA), followed by post-hoc analysis. All statistical analyses were performed using 
JMP (SAS Institute Inc., Cary, USA). 
3.4 Results 
Figure 3.3a shows 31P signal intensities of the mid-tibial cortex superimposed on a 1H 
UTE image in one subject evaluated to determine feasibility of quantification along with 
HA reference samples. Average signal intensities of the four samples are plotted against 
their respective 31P concentrations in Figure 3.3b, showing the expected linear 
relationship between actual concentration and signal intensities (R2 = 0.98). 
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Figure 3.3 In vivo phosphorus intensity map and correlation with calibration samples. a) 31P 
image acquired in a 32 y/o male corresponding to a projection from 6-cm thick slab showing 
tibia, fibula, as well as four HA reference samples, superimposed on a proton anatomic image. 
b) Average signal intensity vs. 31P concentration for the four HA reference samples. Sample 
concentrations were 3, 4.5, 6 and 7.5 mol/L respectively.  
 
Figure 3.4 Total and bound water images of cortical bone. Bone water images from a 48 y/o 
male subject reconstructed from a) first and b) second echo of the dual-echo UTE sequence; c) 
Bound water image from the IR-rUTE sequence. Note that in (c) surrounding soft tissues as 
well as bone marrow within the medullary cavity is selectively suppressed via adiabatic 
inversion, leaving only short-T2 1H density calibration sample and water tightly bound to collagen 
matrix. Image intensity measured from the circular ROI is noticeably higher in the first echo (0.32 
versus 0.03 in the second echo). Also note similar intensity properties of the fasciae (arrows). 
Representative dual-echo UTE and IR-rUTE images are displayed in Figure 3.4a–c. In 
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the two UTE images acquired at TE = 50 and 4600 µs the cortex appears dark with soft 
tissues slightly reduced in intensity at the longer echo time (Figure 3.4a and 3.4b). 
However, the ROI (white circle) signal amplitude in the cortex is significantly greater for 
the first echo (0.32 versus 0.03). Also noticeable in Figure 3.4b are the fasciae (arrows), 
collagenous structures containing very short-T2 hydration water, appearing with 
background intensity as does the cortex. Further, the 1H reference sample present in the 
first echo image is no longer visible in the second echo image given the doped water’s 
very short T2 (~ 320 µs). In the inversion-recovery long-T2 suppressed image of the same 
slice (Figure 3.4c), muscle, subcutaneous and marrow fat are almost invisible while the 
cortex and fasciae now appear bright as does the reference sample. Average SNR, here 
defined as the ratio of the mean signal amplitude within cortical bone to that of the 
background in magnitude images, measured across all subjects were 12 and 6 for the first 
and second-echo UTE images, respectively, and 17 in the IR-rUTE images. Figure 3.5 
demonstrates the ROIs generated using the semi-automatic segmentation algorithm. 
 
Figure 3.5 Cortical bone ROI generated using the semi-automatic algorithm from the first 
echo image of dual-echo sequence i s  shown for four subjects. 
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Figure 3.6 In vivo phosphorus images. 31P projection images (complex summation of a 45-mm 
thick slab) of four subjects with ROIs overlaid. 
Figure 3.6 displays 31P projection images of four subjects (average SNR ~ 10 for tibia). 
The two HA reference samples and the tibia are unambiguously identified on this 
projection from a 45-mm thick volume, and the medullary cavity of the tibia is well 
delineated. Figure 3.7 shows bone water and 31P density color maps for five of the study 
subjects. Bone mineral content (BMC) based on MRI-quantified total 31P content 
(assuming a bone apatite stoichiometry represented by Ca5(OH)(PO4)3 is plotted against 
that measured by HR-pQCT in Figure 3.8, showing the two quantities to be strongly 
correlated. 
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Figure 3.7 Bone water and phosphorus color maps for five of the ten study subjects. 
Differences in the distribution of both bone water and 31P are visually apparent across subjects. 
31P maps were interpolated to match the resolution of the proton images. 
MRI-derived parameters and HR-pQCT reported vBMD are summarized in Table 3.1 for 
all ten subjects. For the three subjects participating in test-retest validation, average 
values from three measurements are reported in the table. Average TW, BW and PW 
concentrations within this subject cohort were 13.99 ± 1.26, 10.39 ± 0.80 and 3.34 ± 1.41 
mol/L, respectively. The average PI was 0.34 ± 0.06, and bone 31P concentration was 
5.29 ± 1.15 mol/L. 
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Figure 3.8 Comparison of BMCs estimated using MRI and HR-pQCT. BMC based on MRI-
derived total 31P content plotted against HR-pQCT derived BMC for a 1-cm thick slab of 
tissue for nine subjects (only nine of the subjects could be scanned because the scanner was 
unable to accommodate the limb size of one subject). For HR-pQCT, BMC was computed by 
multiplying the reported vBMD with the volume of a 1-cm slab. The fitted line was obtained 
after excluding the 62 y/o female subject with abnormally high MRI-derived 31P concentration 
(red arrow). 
Sub-region analysis revealed significant inter-site differences for some but not all of the 
parameters extracted, including pore water and total water fraction (ANOVA, p < 0.001). 
The significantly greater values for PW laterally suggest greater porosity at this location 
(Figure 3.9). 
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Figure 3.9 Regional dependence of pore water. In order to investigate potential spatial 
dependence of MRI-derived parameters, the tibial cortex of each subject was divided into four 
quadrants: anterior, posterior, medial and lateral. ANOVA was applied to compare each 
parameter among these spatial locations, and pore water was found to be significantly higher 
in the lateral region than in the other three quadrants. 
A positive correlation was found between TW and PW (R = 0.81, p < 0.005) while PW 
was negatively correlated with vBMD (R = -0.71, p < 0.05), both expected. Both are 
plausible associations as a change in total water fraction is driven by the change in 
fractional pore space, and the latter is inversely related to osteoid volume fraction and 
thus, at constant mineralization, to BMD. 
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Table 3.1 Bone water, porosity and phosphorus quantification results for all ten subjects 
Subject 
(Age/Gender) 
Bone Water (mol/L) PI 31P (mol/L) vBMD (mg/cm) 
TW BW PW    
29 F 13.87 11.02 2.50 0.32 5.18 1016.8 
31 F 13.19 10.75 2.15 0.37 4.75 1005.8 
32 M 15.23 9.59 5.58 0.44 4.35 N.A. 
39 F 11.71 10.15 1.39 0.33 4.86 1013.5 
47 F 13.96 11.42 2.28 0.35 4.79 1023.0 
48 M 13.77 10.96 2.55 0.26 5.27 1006.6 
62 F 12.62 8.87 3.45 0.24 8.41 1023.0 
63 F 15.54 9.94 5.40 0.36 5.61 986.9 
65 F 14.44 10.06 4.07 0.37 4.72 994.1 
65 F 15.54 11.16 4.06 0.31 4.96 1000.2 
Mean 13.99 10.39 3.34 0.34 5.29 1007.8 
SD 1.26 0.80 1.41 0.06 1.15 12.6 
 
Test-retest results are given in Table 3.2. The CVs for two directly measured water 
quantities, TW and BW, are below 5% for all three subjects, but somewhat greater for 
PW (up to 8.5%), since instead of being a directly quantified parameter, the latter was 
obtained as the difference between two relatively large quantities, making it susceptible 
to errors in measurement. The average CV was 3.8% for the PI and 5.7% for bone 31P 
concentration.  
Table 3.2 Test-retest repeatability in three subjects 
Subject 
(Age/Gender) 29 F 32 M 48 M 
 TW  BW PW PI 31P TW  BW PW PI 31P TW  BW PW PI 31P 
Scan 1 14.16 11.24 2.59 0.33 4.91 15.35 9.61 5.71 0.43 4.37 13.05 10.42 2.34 0.26 5.32 
Scan 2 14.08 11.10 2.63 0.34 5.55 15.56 9.69 5.87 0.43 4.56 14.19 11.20 2.77 0.26 5.53 
Scan 3 13.36 10.73 2.29 0.30 5.08 14.77 9.48 5.16 0.45 4.11 14.07 11.27 2.55 0.27 4.97 
Mean 13.87 11.02 2.50 0.32 5.18 15.23 9.59 5.58 0.44 4.35 13.77 10.96 2.55 0.26 5.27 
SD 0.44 0.26 0.19 0.02 0.33 0.41 0.11 0.37 0.01 0.23 0.63 0.47 0.22 0.01 0.28 
CV (%) 3.18 2.39 7.42 6.44 6.40 2.69 1.10 6.67 2.64 5.20 4.55 4.30 8.42 2.19 5.36 
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3.5 Discussion 
By providing quantitative information on both bone water and 31P — surrogate markers 
of the organic and mineral phases of bone, respectively — the proposed dual-nucleus 
protocol has the potential to differentiate osteoporosis from demineralizing disorders such 
as osteomalacia, which is not achievable with currently available non-invasive 
modalities. As the respective surrogate marker of bone mineral content and matrix, the 
ratio of 31P and BW densities is expected to provide an indirect measure of the degree of 
mineralization. Because the two disorders differ in their underlying mechanisms, accurate 
diagnosis is crucial for effective medical intervention. Absence of ionizing radiation in 
MRI also makes it suitable for longitudinal studies involving one or more follow-up 
exams to monitor patient response to treatment (e.g. monitoring the response to anti-
resorptive treatment for osteoporosis, or vitamin-D supplementation in osteomalacia). 
Compared to bone water, 31P in bone is considerably more challenging to image due to 
the nucleus’ substantially shorter T2 and much longer T1 (160 µs and 18 s for 31P, 
respectively at 3 T [42]). The rapidly decaying signal results in broadened point spread 
function (full width at half maximum ~ 4 mm at the gradient strength of 30mT/m used), 
potentially posing a hard limit on the maximally achievable spatial resolution. This 
limitation, however, is somewhat mitigated by the ZTE-PETRA sequence due to its more 
rapid traversal of k-space (no ramp-sampling), and constant TE within the central k-space 
(PETRA) region. The very short signal lifetime and long T1 of 31P also entail reduced 
SNR compared to that of 1H imaging. 31P also exists in lower concentration than 1H (~ 7 
versus ~ 28 mol/L of 1H in bone water), and has a lower gyromagnetic ratio (by a factor 
of 2.5 relative to protons). The convergence of these factors renders in vivo phosphorus 
	
46	
imaging with adequate resolution and SNR extremely challenging. In fact, in order to 
achieve 31P SNR per unit time comparable to that of bone water, Wehrli et al. projected 
that the spatial resolution would have to be relaxed by a factor of 20 [76]. 
In perhaps the first feasibility study of in vivo solid-state bone 31P MRI by Robson et al. 
in the human tibia at 1.5 T [44], a 2D UTE sequence with a half-sinc pulse was used, 
requiring 64 averages to achieve sufficient SNR. The approximately 14-minute scan time, 
while clinically practical, yielded only a single slice of 60 mm thickness. Although 
quantification was performed in a whole-volume fashion in the current study as well, the 
ultimate goal is to be able to evaluate regional variations of 31P density. More recently, in 
very elegant work, Wu et al. demonstrated the feasibility of in vivo 3D 31P imaging of the 
human wrist at 3 T in 37 minutes [42], although no density quantification was performed. 
In their implementation, a ZTE-type sequence was used in combination with a custom 
wrist coil, which provides relatively high detection sensitivity due to its close proximity 
to the imaging volume. In the only MRI-based human bone 31P quantification study to 
date, Seifert et al. reported an average 31P concentration of 6.74 mol/L in tibia specimens 
[27], versus 5.29 ± 1.15 mol/L observed in the current in vivo work.  
In the present study we utilized a birdcage coil with an inner diameter of 17 cm. 
Although some sensitivity is lost due to its large dimensions, it allows sufficient space for 
placement of calibration samples while providing a relatively large homogeneous B1 
region. Measurements in 1H images of the homogeneous Siemens doped water phantom 
(3.75 g NiSO4 6H2O + 5 g NaCl per 1000 g of H2O) confirmed that signal variation was 
less than 10% within the volume of interest used in this study. Although the 31P transmit 
B1 was not measured directly, it was assumed to have similar homogeneity as that 
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generated by the concentric 31P coil. 
MRI-based bone water quantification at the mid-tibia has been reported in several prior 
studies. Techawiboonwong et al. reported an average TW concentration of 17.4% and 
28.7% by volume (corresponding to 9.7 and 15.9 mol/L) in pre- and post-menopausal 
women, respectively [73]. More recently, Manhard et al. reported an average BW 
concentration of 13.9 mol/L and PW concentration of 3.7 mol/L in an in vivo study of a 
small group of subjects [29]. TW, BW and PW concentrations of 13.99 ± 1.26, 10.39 ± 
0.80 and 3.34 ± 1.41 mol/L found in the current study are consistent with these earlier 
findings. Moreover, our test-retest experiments demonstrated repeatability for TW, BW 
and 31P measurements in vivo on the order of 5–8%, therefore rendering the method well-
suited for longitudinal studies. 
Exclusion of an extreme outlier (see Figure 3.8) suggests negative correlations between 
vBMD and age (R = -0.71), and between BW and PI (R = -0.65) as well as a positive 
correlation between BW and vBMD (R = 0.67) although these associations did not quite 
reach statistical significance (p < 0.08), likely due to limited power of this feasibility 
study. 
There was no significant correlation between MRI-derived 31P concentration and HR-
pQCT derived vBMD in contrast to a previous ex vivo study in human cortical samples 
using similar methodology [27] reporting a positive correlation between the MRI-derived 
31P concentration and CT-derived BMD (R = 0.68, P < 0.005). The same study also 
reported a positive correlation between BW and 31P concentration (R = 0.77, P < 0.005). 
However, the current study did yield a strong positive correlation between BMC 
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measured with MRI and that measured with HR-pQCT (R = 0.98, p < 0.0001), as shown 
in Figure 3.8. Although this correlation was obtained with the same outlier exclusion 
stated above, statistical significance was still present even without exclusion of this 
particular subject (R = 0.67, p < 0.05). 
The rationale behind choosing the tibia as the imaging location is based on the following 
considerations. First, its proximity to the body surface and the overall geometry of the 
lower leg makes the tibia technically more amenable to examine with an optimized RF 
coil than more deep-lying structures such as femoral neck. Second, the mid-tibial cortex 
is relatively thick (5–7 mm). Third, since at stance, for instance, a large proportion of 
stress that governs remodeling in bipeds is along the vertical axis of the body, it is 
plausible that bone loss at the tibia is similar to that at typical fracture sites such as the 
proximal femur and spine, but this conjecture obviously would require detailed scrutiny 
in future studies. Fourth, degenerative bone disease, notably osteoporosis, is a systemic 
disorder. It has long been known that age-related cortical bone pore volume expansion 
occurs at multiple anatomic locations, with detailed studies having been conducted at the 
humerus [77], the femoral shaft [78], radius [79], or ilium [80]. We also note that in prior 
work by some of the authors, MRI measures of the calcaneus, for instance, distinguished 
osteoporotic fracture patients from controls as well as or better than did BMD of the 
proximal femur or vertebrae [81]. Sub-region analysis showed site-specific differences 
for some of the parameters. While the clinical significance of such observations is 
currently not known and beyond the scope of this article, it is likely that remodeling- 
related effects in response to drug intervention are anatomic site-dependent. 
In this work, UTE was used for imaging bone water and ZTE for bone phosphorus. 
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Seifert et al. showed experimentally that ZTE-PETRA provides SNR superior to its UTE 
counterpart for 31P imaging [41]. Theoretically, bone water imaging should also benefit 
from ZTE for similar reasons. However, the peak B1 of the coil limited the maximally 
achievable flip angle of a 16 µs rectangular pulse for 1H to about 9°. In order to increase 
the flip angle (and SNR), pulse duration would have to be increased. This is not possible 
in ZTE: a pulse duration greater than twice the dwell time would cause severe excitation 
selectivity within the imaging field-of-view [50]. Therefore, UTE was utilized in lieu of 
ZTE for 1H imaging so the flip angle could be optimized by increasing the RF pulse 
duration. 
The present work has limitations. As a feasibility study it falls short of providing 
adequate power to test some of the associations examined. Second, the study used a 
‘population average’ value of cortical bone T1 values in computing the MR parameters. 
However, Seifert et al. demonstrated that the longitudinal relaxation time of bone 31P 
scales with the degree of mineralization [41], thus the assumed T1 may potentially deviate 
from actual values thereby adversely impacting quantification. This is less of a problem 
as long as the bone is normally mineralized (unlike in bone demineralizing disorders such 
as osteomalacia). The errors incurred from using an average 31P T1 value need be 
examined, as well as the feasibility of T1 measurement within a maximum allowable 
procedure time of one hour. While deriving BW concentration from IR-rUTE images, 
BW magnetization was assumed to recover from zero after each inversion since the 
residual longitudinal magnetization immediately following the HS pulse has been found 
to be negligible [82]. Nevertheless, it is conceivable that saturation is not always 
complete. Further, a single inversion delay was used to null all long-T2 species, as it has 
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been shown that the optimal delay is similar for tissue water and fat as long as TR < T1 
[46]. However, Figure 3.4c lends strong support of effective suppression of both bone 
marrow and surrounding soft tissues. Another potential source of systematic error is 
imperfect nulling of PW spins at the time of the excitation pulse given the wide range of 
their T1 values [39]. 
3.6 Conclusion 
In conclusion, the present feasibility study, while limited in scope, highlights the 
potential of solid-state MRI for the quantitative evaluation of cortical bone matrix and 
mineral properties in the form of an integrated, single-session quantitative study of bone 
water and mineral phosphorus. 
3.7 Appendix 
1H UTE (31P ZTE) 
The transverse magnetization immediately after RF pulse in UTE and ZTE is given as: 
                                        F = M!" = f!" ∙
1− e
!!"
!!
1− f! ∙ e
!!"
!!
,                                        [A 3.1] 
where fxy and fz are mapping functions reflecting the response of longitudinal and 
transverse magnetization to a rectangle pulse the duration of which (τ) is comparable to 
the spin’s effective transverse relaxation time (T2*), and are defined as: 
                            f!" = γB!τe
!!
!!!
∗ sinc( γB!τ ! −
!
!!!∗
!
),                                      [A 3.2] 
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and 
f! = e
!!
!!!
∗ [cos γB!τ ! −
τ
2T!∗
!
+
τ
2T!∗
sinc( γB!τ ! −
τ
2T!∗
!
)]      [A 3.3] 
In the regime of τ << than T2*, these two mapping functions reduce to sin(γB1τ) and 
cos(γB1τ) respectively. 
1H IR-rUTE 
The signal of inversion recovery-prepared UTE is however, of a different steady-state. In 
order to derive an analytical solution, the magnetizations of bound water and reference 
sample were assumed to be fully saturated immediately after each adiabatic inversion 
(actually, numeric Bloch equation simulation indicated a residue of only ~5%), therefore, 
longitudinal magnetization of bound water (reference sample) right before the first UTE 
readout is:  
                                                           M!! 1 = 1− e
!!"!! ,                                                [A 3.4] 
with TI being the inversion recovery delay. And the longitudinal and transverse 
magnetization right after the RF pulse could be written as: 
                                                                M!" 1 = f!" ∙M!! 1 ,                                                  [A 3.5]	
                                                          M!! 1 = f! ∙M!! 1 ,                                              A 3.6 	
where fxy and fz are the same mapping function as described above. By the time of next 
RF excitation, transverse magnetization would completely vanish while longitudinal 
magnetization would have recovered for a period of (TRr - τ) (Fig 3.2b), so the initial Mz 
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for all the rest six UTE readouts would be:	
                                             M!! i = 1− 1−M!! i− 1 e
! !"!!!!! ,                         [A 3.7] 
and the average value of transverse magnetization following all seven excitation is used 
to represent steady-state signal for bound water and reference sample: 
                                                       IR! =
M!" i!!!!
7 ,                                                   [A 3.8] 
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CHAPTER 4: IN VIVO 31P RELAXATION TIMES AND 
THEIR IMPLICATIONS ON MINERAL 
QUANTIFICATION 
4.1 Abstract 
Purpose: The inter-subject variations in bone phosphorus T1 and T2*, as well as the 
implications on in vivo 31P MRI-based bone mineral quantification, were investigated at 3 
T field strength. 
Methods: A technique that isolates the bone signal from the composite in vivo 31P 
spectrum was first evaluated via simulation and experiments ex vivo and subsequently 
applied to measure the T1 of bone 31P collectively with a spectroscopic saturation 
recovery sequence in a group of healthy subjects aged 26 to 76 years. T2* was derived 
from the bone signal line width. The density of bone 31P was derived for all subjects from 
31P zero TE images acquired in the same scan session using the measured relaxation 
times. Test–retest experiments were also performed to evaluate repeatability of this in 
vivo MRI-based bone mineral quantification protocol. 
Results: The T1 obtained in vivo using the proposed spectral separation method 
combined with saturation recovery sequence is 38.4 ± 1.5 s for the subjects studied. 
Average 31P density found was 6.40 ± 0.58 mol/L (corresponding to 1072 ± 98 mg/cm3 
mineral density), in good agreement with an earlier study in specimens from donors of 
similar age range. Neither the relaxation times (P = 0.18 for T1, P = 0.99 for T2*) nor 31P 
density (P = 0.55) was found to correlate with subject age. Average coefficients of 
variation for the repeat study were 1.5%, 2.6%, and 4.4% for bone 31P T1, T2*, and 
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density, respectively. 
Conclusion: Neither 31P T1 nor T2* varies significantly in healthy adults across a 50-year 
age range, therefore obviating the need for subject-specific measurements. 
4.2 Introduction 
Recent advances in solid-state MRI have made possible imaging of the mineral portion of 
bone by means of 31P UTE and ZTE pulse sequences [49, 83], including methods for 
quantification of 31P density [27, 84]. The resulting measurements typically yield 
apparent density only, similar to 3D CT. However, MRI has the potential to quantify true 
mineralization density, often referred to as degree of mineralization of bone [85], which 
so far could be obtained only on specimens by means of autoradiography [86] or 
synchrotron radiation micro-tomography [87]. An assessment of degree of mineralization 
of bone requires knowledge of the unmineralized fraction of the bone, essentially the 
density of the collagen matrix [88]. The protons of collagen have T2 on the order of 50 
ms and are therefore not amenable to detection by in vivo MRI methods. However, as 
pointed out in a recent paper by Seifert et al., the collagen-associated water can be 
detected and quantified, thereby possibly serving as a surrogate for collagen itself [27]. 
Knowledge of degree of mineralization of bone is of interest because this quantity would 
allow differentiation of osteoporosis from osteomalacia. The former is characterized by 
loss of bone volume, with the remaining bone tissue properly mineralized, whereas in the 
latter case the osteoid is poorly mineralized even if the total volume may be normal. Of 
note is that current x-ray based densitometric techniques are unable to make this 
clinically important distinction. Both conditions are common in older people, but the 
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treatment of the two disorders is very different. 
The practicality of accurate quantification of collagen-bound water has been 
demonstrated by several laboratories [30, 84, 88]. Quantification of mineral phosphorus 
by MRI in live human subjects, however, is far more difficult, although its feasibility has 
been reported recently [84]. Detection sensitivity scales as the ratio of T2/T1 (~10-5 for 31P 
in apatite-like solids such as bone mineral), which is compounded by the 31P nucleus’ 
smaller gyromagnetic ratio (γ31P/γ1H = 0.401), lowering achievable SNR by another order 
of magnitude [76]. Further, quantification requires co-imaging a density calibration 
sample containing, for example, synthetic calcium hydroxyl apatite. Because the T1 of the 
reference sample differs from that of bone, a signal intensity correction is needed to 
account for the differences. Thus, accurate knowledge of the 31P relaxation properties of 
the bone is required to derive its density. 
31P T1 relaxation in bone mineral is dominated by dipole–dipole relaxation with nearby 
protons, most likely crystal water or the hydroxyl ion. The relaxation rate (1/T1) is 
proportional to the product of the squares of the gyromagnetic ratios of the interacting 
spins (1H and 31P) and inversely proportional to the sixth power of the inter-nuclear 
distance. It is the relative remoteness of nearby protons and their scarcity that renders this 
mechanism relatively ineffective. Nevertheless, as shown previously at 3 T, 80% of the 
relaxation rate is governed by 1H-31P dipole–dipole interaction, as determined by 
deuterium exchange of the labile protons [41]. On the other hand, the transverse 
relaxation rate (1/T2) responsible for the very large line width of mineral 31P has been 
attributed to homonuclear 31P-31P dipole–dipole coupling [89]. 
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A number of previous studies have reported bone 31P T1 relaxation times [27, 41, 42, 44]. 
Seifert et al. measured bulk 31P T1 in lamb cortical bone [41] and subsequently in human 
bone specimens [27] using a saturation recovery (SR) method. Earlier, Robson et al. had 
reported image-based 31P T1 measurements in the human tibia in vivo with both SR and 
variable flip angle UTE at 1.5 T, finding average values of 8.6 s in seven subjects [44]. 
More recently, Wu et al. measured 31P T1 at 3 T in two subjects by means of a 
progressive saturation method, one spectroscopically (i.e., non-spatially resolved) and the 
other using a low-resolution image-based method, reporting values of 17 and 19 s, 
respectively [42]. The much longer values found at 3 T suggest a strong field 
dependence, which was studied systematically more recently by Seifert et al. [41], who 
found T1 to increase mono-tonically with field strength in lamb cortical bone from 12.8 ± 
0.5 s at 1.5 T to 97.3 ± 6.4 s at 11.7 T. 
Most prior measurements, however, were either conducted ex vivo in various species, or 
in vivo using methods that required very long scan times. In addition, measurements in 
vivo may be affected by contributions from soft tissue 31P signals arising from 
phosphorus metabolites. Robson et al. [44] discounted such effects as significant given 
that bone 31P concentrations are larger by about three orders of magnitude than those of 
muscle metabolites. In the work by Wu et al., the experiments were conducted in the 
wrist [42], which is covered by only a thin layer of soft tissue. In the tibia, however, the 
volume fraction of muscle adjacent to bone is much larger. Thus, contribution of 31P 
signal from metabolites could become more significant. 
The primary objectives of the present work were to investigate means to isolate and 
measure bone 31P T1 values and to determine the implications of inter-subject variations 
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in T1 on quantification of bone 31P content. To this end, a technique to separate bone 31P 
signal from those of the metabolites was first evaluated via simulation and ex vivo 
experiments and subsequently applied in vivo to measure bone 31P T1 relaxation times in 
a group of healthy subjects of wide age range. The measured relaxation properties were 
then used to estimate bone 31P density from ZTE images. Finally, repeatability of the 
MRI-based bone mineral quantification protocol incorporating relaxation measurements 
was evaluated in vivo. 
4.3 Materials and Methods 
4.3.1 T1 Measurement Sequence 
T1 of most tissues can be measured accurately by means of the inversion recovery 
strategy. However, due to its extremely short T2, it is impossible to adequately invert the 
magnetization of bone 31P. Therefore, an SR technique was used to measure 31P T1 [41]. 
Furthermore, the inherently low SNR of bone 31P would make reliable image-based T1 
measurements prohibitively long. For this reason, a spatially non-selective spectroscopy-
based method was implemented. 
The SR spectroscopic sequence used starts off with a saturation (SAT) block to saturate 
the 31P spins (Figure 4.1).  Each of the 12 SAT pulses is followed by a spoiler gradient to 
enhance saturation and reduce echo formation using multiple gradient orientations [27]. 
After a saturation recovery delay (TSR), an FID is collected. TSR is stepped from one 
acquisition to the next to sample the T1 recovery process. The set of TSRs chosen 
consisted of 2, 4, 8, 16, 32, 64, 128, and 256 s, resulting in a total scan time of 8.5 min. A 
1H/31P dual-frequency birdcage coil (Rapid Biomedical, Rimpar, Germany) was used. At 
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maximum allowable peak power, a 60° nominal flip angle could be achieved at 120 µs 
pulse duration, which is less than 31P T2 in bone mineral. This flip angle was used for 
both saturation and excitation.  
 
Figure 4.1 Diagram of the SR-prepared spectroscopy sequence, consisting of a saturation 
block of twelve 120-µs 60° hard pulses, 2 ms apart, and each followed by a spoiler. Spoilers 
are applied along different orientations for optimal de-phasing [27]. After a delay of TSR, 
signal is excited with another 120-µs 60° hard pulse and an FID is acquired at 250 kHz 
bandwidth. For further details, see text. 
Bloch equation simulations showed that twelve 60° constant-phase RF pulses can achieve 
> 99.5% saturation for 31P from both bone and metabolites. Signal was acquired 20 µs 
after excitation with a dwell time of 4 µs, and a total of 4096 data points were collected. 
However, the first eight points affected by coil ringing during transmit/receive switching 
were removed before reconstruction. 
Whole-volume spectroscopy with short non-selective RF pulses was indicated to capture 
the short, low-SNR 31P signal. However, this approach entails two potential problems: 
First, because the signal is the integral over the entire sensitivity region of the 
transmit/receive coil, 31P signal from all tissues is detected, not only from bone. As 
demonstrated in Figure 4.2, 31P peaks from muscle metabolites are superimposed on the 
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broad bone spectrum. Accurate measurement of bone phosphorus requires proper 
isolation of the bone peak from all other phosphorus signals. Second, whole-volume 
measurement is sensitive to B1 inhomogeneity, which could adversely affect saturation. 
Both issues were investigated via simulation as well as experiment.  
 
Figure 4.2 In vivo 31P spectrum obtained from the calf of a healthy subject at 3 T. The broad 
peak corresponds to the 31P in bone mineral, while the superimposed narrow peaks are from 
muscle metabolites. 
4.3.2 Isolation of the Bone 31P Spectrum 
In order to separate the bone spectrum from the composite signal shown in Figure 4.2, a 
spectral subtraction method was used, yielding two spectra at each TSR during post-
processing. Removal of the first 150 data points (corresponding to fast-decaying bone 
signal) from each FID results in a spectrum dominated by the much narrower metabolite 
signal components (Spec_Metabolite). The other spectrum was generated after removing 
150 points from the end of the original FID, resulting in a composite spectrum consisting 
of both bone and metabolite peaks (Spec_Total). In this manner, both FIDs have the same 
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number of data points. After appropriate phase correction (both zeroth and first order), 
subtraction between the real parts of the two spectra yielded the bone 31P spectrum 
(Spec_Subtract). Subsequently, the bone 31P spectrum from each TSR was fitted to a 
Lorentzian. The processing steps are schematically illustrated in Figure 4.3. The total 
peak area is then fitted to the three-parameter model to estimate T1 (Equation 4.1): 
                                                     S = S! ⋅ (1− 1− Q ⋅ e
!!"#
!! )+ N,                                    [4.1]  
Where S0 is the equilibrium signal of bone 31P; Q represents the proportion of unsaturated 
31P spins in bone following the SAT pulses, which should ideally be zero for a perfect 
saturation; and N is noise. T2* of bone 31P was estimated as 1/(π × FWHM), for which 
FWHM is the full width at half maximum of the fitted Lorentzian. Although chemical 
shift anisotropy, homonuclear and heteronuclear scalar coupling are expected to cause 
deviations from Lorentzian line shape [90], we found the latter to be a reasonable 
approximation. Lastly, the Lorentzian conforms to the concept of T2* as the time constant 
for mono-exponential decay.  
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Figure 4.3 Workflow for isolating the bone 31P spectrum from the composite signal containing 
both bone 31P and 31P metabolites. Spec_Total (overall signal) and Spec_Metabolite 
(predominantly metabolite signal) are generated from different portions of the FID. After 
phase correction, bone spectrum is obtained via subtraction of the two, which is subsequently 
fitted to a Lorentzian.  
4.3.3 Simulation 
Simulation experiments were carried out to investigate the accuracy of the proposed T1 
measurement method in the presence of 31P-containing metabolites. Based on the in vivo 
31P spectrum observed both in this study as well as in the literature [91], five 31P sources 
from metabolites — α-adenosine triphosphate (ATP), β-ATP, γ-ATP, PCr, and Pi — 
were considered. Chemical shifts of the metabolites were measured in vivo, whereas 
relaxation properties are based on values reported previously by Meyerspeer et al. [92]. 
T1 and T2* of bone 31P were assumed to be 35 s and 200 µs based on an initial in vivo test 
scan. Bone 31P concentration measured ex vivo by Seifert et al. [27], calf muscle 
metabolites concentrations measured in vivo by Kemp et al. [91], and volume of cortical 
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bone and muscle in the lower leg measured from conventional 3D gradient echo (GRE) 
images of four healthy subjects were used to estimate the proportions of bone and 
metabolites in the total signal. The simulation also incorporated B1 field inhomogeneity 
along the z-axis (where most variation is expected for non-selective whole-volume 
measurements). The volume coil used is of a fixed birdcage design, with an inner 
diameter of 17.6 cm that is large enough to pass the foot through. It consists of two 
concentric-element coils, tuned to 1H and 31P, respectively. The two coils have the same 
physical size and number of rungs (eight), by are rotated relative to each other by 22.5°. 
Therefore, the B1 fields of the two coils are expected to have similar characteristics. 
Because it is difficult to map the B1 of the 31P channel due to the inherently low SNR, the 
proton channel of the dual-frequency coil was used for B1 mapping, which was 
accomplished with the Bloch-Siegert technique [93] by means of a homogeneous doped 
water phantom. Because the phantom was not sufficiently long to cover the entire 
sensitivity region of the coil, the measured B1 profile was fitted to a Gaussian function to 
estimate B1 in the missing outermost regions. Receive sensitivity (B1-) was assumed to be 
the same as transmit B1 (B1+) from the principle of reciprocity as the same birdcage 
structure was used for both transmission and reception. Parameters of the simulated SR 
sequence were the same as described above. 
4.3.4 Ex Vivo Validation 
For further validation, two sets of ex vivo experiments were performed on a 3 T (49.9 
MHz) TIM Trio system (Siemens Medical Solutions, Erlangen, Germany) with the 1H/31P 
dual-frequency coil. The first experiment was aimed at investigating the effect of 
inhomogeneous B1 on the accuracy of T1 measurements. Four lamb tibiae (with soft 
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tissue and articular cartilage removed) were cut into small sections of approximately 5 
cm length, and T1 and T2* were measured with two different specimen placements: 1) all 
bone fragments were positioned within about 5 cm from the coil center, at which location 
the flip angle should be close to the nominal value; and 2) the fragments were evenly 
distributed ± 20 cm along the coil axis, which represents the entire sensitive region of the 
coil (Figure 4.4a), in order to cover the range of flip angles from the nominal value to 
near zero. In the second experiment, the performance of the proposed method for bone 
signal isolation was evaluated. To this end, a lamb hind leg, including femur, tibia, and 
surrounding muscles, was scanned in two different ways. T1 and T2* measurements were 
first done with soft tissue intact and the scan centered at the tibial mid-shaft. This 
measurement was repeated for four times with repositioning each time to test 
repeatability. Subsequently, the surrounding soft tissues (mostly muscle) were removed 
and the femur and tibia were harvested. The relaxation times of the two specimens were 
measured separately, with the specimen aligned along the long axis of the coil. Each bone 
was scanned three times with repositioning. These measurements were carried out within 
24 hours of soft tissue removal, and caution was taken to maintain the hydration level of 
the bone during storage as well as the experiment. All specimens were collected from 
freshly slaughtered animals from the local market. 
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Figure 4.4 (a) Measured B 1 +  profile along z-axis of the coil and the fitted Gaussian. (b) 
Simulated saturation profile following the SAT module of the SR sequence in the presence of 
B1+ inhomogeneity depicted in (a) for different 31P signal sources. (c) Relative amplitude of the 
signal as a function of spatial location plotted versus TSR. The pair of small peaks appearing at 
the shorter TSRs is due to incomplete saturation at the most distal coil locations. 
4.3.5 In Vivo 31P Imaging and Quantification 
Ten healthy subjects of both genders (two males, eight females; age range: 26–76 years; 
mean (SD) = 50.4 (16.6) years old, BMI < 30) were recruited under an IRB-approved 
protocol. For each subject, the left mid-tibia (centered at 38% of tibia length from medial 
malleolus, where the cortical bone is the thickest [27]) was imaged with the same MRI 
system and coil used for the ex vivo experiment. After localization, 31P transmit power 
was calibrated manually by incrementing the flip angle and maximizing the equilibrium 
calf muscle phosphocreatine signal [84]. Next, the SR-prepared spectroscopic sequence 
described above was applied to measure T1 of bone 31P. Three-dimensional 31P images 
were subsequently acquired with a custom-designed ZTE-PETRA pulse sequence [84]. 
The 31P ZTE-PETRA sequence was optimized for the experimentally observed relaxation 
parameters. Initial test scans in the tibia indicated an approximate bone 31P T1 of around 
35 s. Therefore, flip angle was set to the Ernst angle of 5.3° (16-µs hard pulse) for a 150 
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ms TR. Sampling frequency bandwidth was 125 kHz, filling 3D spherical k-space with 
8000 spokes and 895 single point acquisitions (PETRA radius = 6, hence, the effective 
TE was dwell time × PETRA radius = 48 µs), resulting in a total scan time of 22.5 min. 
An FOV of (250 mm)3 was prescribed, and 50 points along each spoke were acquired for 
reconstruction, leading to a nominal isotropic spatial resolution of 2.5 mm. Additionally, 
a 1H image at the same location was also acquired with the manufacturer’s 3D GRE 
sequence. From this, the tibial cortex was segmented using ITK-SNAP [94] to derive the 
bone volume, which was used for 31P density calculation. Aside from the localizer and 
the 3D GRE sequence, all custom sequences were implemented in SequenceTree [95]. 
31P ZTE-PETRA image data were acquired in the presence of a synthetic hydroxyapatite 
reference sample (Sigma-Aldrich, St. Louis, MO) with a known 31P density of 9.5 mol/L 
(T1 = 42.2 s, T2* = 145 µs) placed adjacent to the tibia. Following image reconstruction, 
signal intensity of cortical bone was compared to that of the reference sample to 
determine the amount of 31P in bone as described in Equation 3.1, where Iref and Ibone are 
image intensities measured within the reference sample and cortical bone. Whereas Fref 
and Fbone (Equation A 3.1) are calculated steady-state signals using the respective 
relaxation properties given, where fxy (Equation A 3.2), fz (Equation A 3.3) are the 
mapping functions that describe the response of the magnetization to a constant-
amplitude RF pulse, applicable when the pulse width s is comparable to or less than T2* 
[96]. Bone 31P meets these requirements [27, 84] and, under some conditions, also those 
of bone water constituents [73]. 
To investigate repeatability, the above protocol was performed three times in three of the 
ten subjects, with repositioning between scans. Coefficients of variation were calculated 
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for cortical bone volume estimated from ITK-SNAP segmentation, relaxation times, and 
density of bone 31P for each of the three test-retest subjects. 
4.4 Results 
4.4.1 Simulation 
The B1 field of the coil along its axis, measured by the Bloch-Siegert phase shift method 
[93] and the fitted Gaussian function, is shown in Figure 4.4a. Figure 4.4b depicts the 
simulated saturation profile for various 31P-containing species in the presence of such B1 
inhomogeneity following the 12-pulse SAT module of the SR sequence. Due to the 
gradual decrease in the strength of the transmit field toward the edges of the coil, the 
saturation profile is characterized by a relatively large transition band (shaded area). As a 
result of its much shorter T2, which causes the flip angle to deviate from the nominal 
value [97], the bone has a narrower full saturation region than that of the metabolites. 
Figure 4.4c shows the simulated profile of the received bone 31P signal strength as a 
function of spatial location for different TSRs. It is worth noting that, although saturation 
is incomplete toward the edges of the coil due to rapid B1 field drop-off, the contribution 
from the unsaturated spins is small because of the low coil sensitivity in those regions 
(Figure 4.4c). 
Figure 4.5a shows the simulation results of the effects of metabolite signal fraction on 
the bone phosphorus relaxation times computed using the proposed spectral separation 
method and taking into account the B1 inhomogeneity along the coil axis. T1 is 
increasingly underestimated with increasing fraction of metabolite 31P in the total signal, 
whereas T2* is overestimated. If 15% of the total signal were to arise from metabolites, 
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the error in T1 and T2* would be approximately -10% and +24%, respectively. According 
to Figure 4.5b, which plots the error in quantified [31P] as a function of T1 and T2* error, 
the above relaxation time errors result in [31P] being underestimated by approximately 
9.7%. Note that in the absence of metabolites, T1 and T2* errors are less than 1% and 3%, 
respectively, even in the presence of large B1 field variations along the length of the coil. 
 
Figure 4.5 (a) Error in bone phosphorus relaxation times measured with the proposed method 
as a function of the fraction of metabolites in the total signal. (b) Error in quantified [31P] as a 
function of error in T1 and T2*. 
4.4.2 Ex Vivo Validation 
In the ex vivo experiment that investigated the effect of B1 inhomogeneity on relaxation 
measurement, the T1 and T2* were 26.7 s and 167.7 µs when all the lamb tibiae fragments 
were placed near the coil center. When the fragments evenly spanned the entire coil 
sensitivity region along its long axis, T1 and T2* were found to be 25.1 s and 173.6 µs, 
respectively. In the second ex vivo experiment that evaluated the impact of presence of 
soft tissue, the T1 and T2* of bone were 27.3 ± 0.6 s and 229.6 ± 1.5 µs, respectively, in 
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the presence of surrounding soft tissue. After soft tissue removal, T1 and T2* of tibia were 
measured to be 28.2 ± 0.8 s and 170.9 ± 0.8 µs, respectively, whereas those of femur 
were 26.7 ± 0.3 s and 168.7 ± 1.0 µs, respectively. 
4.4.3 In Vivo 31P Measurement and 31P Quantification 
Figure 4.6 illustrates the T1 estimation using the proposed spectral separation method 
from an SR spectroscopic data set of one subject. Figure 4.7 displays structural GRE 
images acquired from three subjects as well as the segmented tibia using ITK-SNAP for 
computing cortical bone volumes. Phosphorus images used for [31P] quantification are 
also shown in Figure 4.7. Bone 31P relaxation times and [31P] measured for all ten 
subjects are given in Table 4.1. R2 for Lorentzian fitting of the isolated bone spectrum 
(following subtraction of the metabolite spectrum) and subsequent mono-exponential T1 
fitting were greater than 0.97 and 0.99, respectively. To facilitate comparisons with x-ray 
based imaging modalities, Table 4.1 also includes bone mineral density computed from 
our MR-measured [31P], assuming Ca5(OH)(PO4)3 as the mineral stoichiometry. Even 
though bone mineral was not measured independently by quantitative CT, the 31P 
density-derived values are within the expected range of densitometric measurements.  
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Figure 4.6 (a) Total and (b) metabolite spectra generated from an SR dataset of one of the 
subjects. (c) Isolated bone spectra and corresponding Lorentzian fits. (d) T1 estimation via 
mono-exponential fitting of the integral of Lorentzian lines in (c). 
Given the similarity in relaxation times across the ten subjects, 31P concentrations were 
also computed using population-averaged T1 and T2* values, resulting in an average 
difference of about 2.4% compared to values computed using individually measured 
relaxation times. Because the muscle-to-bone ratio is expected to be largely invariant 
(e.g., Ref. [98]), a retrospective correction of the derived 31P concentration, which 
accounts for the metabolite fraction, can also be applied. It is preferable, however, to 
apply the correction to the relaxation constants because the apparent 31P concentrations 
are pulse sequence-dependent (Equation 3.1 and Equation A 3.1). Doing so based on 
the 92.5% average bone 31P fraction for the study group yielded T1 and T2* errors of 
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about -4.3% and +10.5%, respectively, resulting in a 31P density error of approximately 
4.6%. Relaxation times corrected for this error, as well as 31P concentrations calculated 
using an average of the corrected T1 and T2* values, are given in Table 4.1 too. None of 
the parameters — [31P] (P = 0.55), T1 (P = 0.18), or T2* (P = 0.99) — was correlated with 
subject age. Coefficients of variation for cortical bone volume, T1, T2*, and [31P] were 
2.2%, 1.5%, 2.6%, and 4.4%, respectively (Figure 4.8). 
 
Figure 4.7 Axial 3D GRE images of the calf from (a) 30 y/o female, (b) 44 y/o male and (c) 
51 y/o female. (d-f) Corresponding segmented cortical bone volumes. (g-i) 31P ZTE image 
resulting from averaging of 18 slices. 
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4.5 Discussion 
The present work sheds some light on the question of whether bone mineral 31P T1 and 
T2*  need to be measured individually to ensure quantitative accuracy in the measurement 
of phosphorus mineral density by solid-state MRI techniques or whether the use of global 
averages is adequate for quantification. The data obtained in the present work in the tibial 
cortex of ten healthy test subjects, ranging in age from 26 to 76 years, suggest only 
minimal inter-subject variations without a dependence on subjects’ age or gender (Table 
4.1). 
Table 4.1 Cortical bone 31P relaxation times and concentrations: MR = measured; CR = 
systematic error corrected using population-averaged relaxation times (for detail see text); 
Δ[31P] (%) = estimated systematic error; BMD = bone mineral density computed from 31P 
densities using stoichiometric calcium hydroxyapatite (for detail see text). 
 MR CR [31P] (mol/L) Error BMD 
Age/Gender T1 (s) T2* (µs) T1 (s) T2* (µs) MR CR Δ[31P] (%) MR CR 
26 M 36.1 185.7 37.7 168.1 5.56 5.81 4.50 931 973 
30 F 35.7 202.7 37.3 183.4 6.45 6.94 7.60 1080 1162 
33 M 34.7 213.9 36.3 193.6 5.97 6.61 10.72 1000 1107 
44 M 38.7 190.1 40.4 172.0 7.57 7.68 1.45 1267 1286 
51 F 37.8 191.8 39.5 173.5 6.50 6.69 2.98 1088 1120 
58 F 37.6 188.6 39.3 170.7 5.92 6.08 2.70 991 1018 
60 F 36.7 185.7 38.3 168.1 5.70 5.91 3.68 954 990 
61 F 35.0 206.4 36.6 186.8 5.62 6.13 9.07 941 1026 
65 F 36.9 206.5 38.6 186.9 5.61 5.96 6.24 939 998 
76 F 38.5 198.4 40.2 179.5 6.02 6.19 2.82 1008 1036 
Mean 36.8 197.0 38.4 178.3 6.09 6.40 5.18 1020 1072 
SD 1.4 10.0 1.5 9.0 0.62 0.58 3.09 103 98 
	
The measurement of the relaxation times, in particular T1, was found not to be entirely 
straightforward. An image-based measurement, consisting of an appropriate SR 
preparation module preceding the ZTE excitation and readout, would be desirable 
because it would provide the spatial dependence of relaxation times. However, such an 
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approach is entirely impractical due to excessive scan times. We therefore elected a 
spectroscopic approach forgoing spatial selectivity, an approach previously chosen by 
Seifert et al. for T1 quantification in human specimens [27]. The loss of spatial 
selectivity, one could argue, is acceptable given the systemic nature of most degenerative 
bone disorders. However, the presence of major muscle groups in the tibia poses unique 
challenges to the measurement of bone 31P T1 in vivo. The spectrum is a superposition of 
the spectra from bone and muscle phosphorus metabolites, and although the latter are far 
lower in concentration than mineral phosphate, this disparity is partially offset by the 
muscles’ much larger volume. In vivo concentrations of three main 31P-containing 
metabolites — PCr, Pi, and ATP — are approximately 33, 4.5, and 8.2 mM, respectively, 
in human calf muscle [91]. Average cortical bone 31P concentration reported by Seifert et 
al. was 6.74 ± 1.22 mol/L in the tibial cortex of 16 donors, covering the entire adult age 
range [27]. These data, along with muscle and bone volumes estimated by standard GRE 
imaging in all ten subjects, suggest that tibial bone phosphorus accounts for > 90% of 
total amount of 31P present in vivo at the tibial location. However, the much greater 
visibility of the metabolite signals, given their 31P signal line widths being at least two 
orders of magnitude lower than those of the phosphate resonances from bone [92, 99], 
means that their contributions to the total signal cannot be ignored. Here, the authors 
made use of the large differential in T2* between the two 31P species and thus the lifetime 
of their FIDs for their separation. Another issue examined is the effect of RF 
inhomogeneity in the non-spatially selective measurement as the B1 field falls off in axial 
direction from the center toward the coil boundaries, which raises the question as to the 
effectiveness of saturation of spins in more distant locations. However, the data obtained 
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by both simulation and experiment show that the 12-pulse saturation train is effective 
across a large range of excitation flip angles as they occur along the coil axis, yielding 
accurate T1 and T2* values in the absence of metabolites. 
 
Figure 4.8 ANOVA analysis showing test-retest repeatability of bone phosphorus T1, T2* 
measured with proposed method, and bone phosphorus density estimated from 31P ZTE image 
using measured relaxation times. 
With bone comprising > 90% of the total signal, T1 and T2* errors are limited to about 
6% and 15%, respectively (Figure 4.5a). The underestimation of T1 and overestimation 
of T2* both lead to lower computed phosphorus density. Because ZTE-PETRA is 
essentially a steady-state GRE sequence (Equation A 3.1), and therefore inherently T1-
weighted, lower computed T1 translates into a higher calculated steady-state signal level 
(Fbone in Equation 3.1), and therefore lower estimated 31P density, which scales as the 
ratio of observed image intensity to its predicted steady-state value. Overestimated T2*, 
according to Equation 3.1 (due to the exponential term), will also translate into lower 
computed 31P density. 
Several observations are worth noting from the specimen experiments. First, the very 
similar values of T1 and T2* obtained from the two arrangements of tibia specimens 
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confirm the simulation results, indicating that relaxation measurements are relatively 
insensitive to B1 inhomogeneity. The likely reason for this finding is that, although 
inhomogeneous transmit fields cause imperfect saturation, the unsaturated spins have 
relatively small contribution to the total detected signal due to lower coil sensitivity in 
those regions. This holds true as long as the same coil is used for both transmission and 
reception, due to the principle of reciprocity, as it applies to the birdcage coil used. The 
close agreement between the bone T1 values measured in the presence of soft tissue (27.3 
± 0.6 s) and those measured with soft tissue removed (tibia T1 = 28.2 ± 0.8 s; femur T1 = 
26.7 ± 0.3 s) confirm the effectiveness of the proposed method at isolating bone spectrum 
from the composite signal. Furthermore, the T1 values of lamb cortical bone measured ex 
vivo in the current study are consistent with those reported previously by Seifert et al. (T1 
= 26.0 ± 1.4 s; T2* = 189 ± 2.2 µs), which were also obtained from the same animal 
species, anatomic location, and field strength [41]. However, the obviously elevated T2* 
of bone in the presence of soft tissue is consistent with the result of the simulation 
experiment and may lead to underestimation in [31P]. 
As noted above, the variation of T1 across subjects (age range = 26–76 years) observed in 
this study is unexpectedly small (38.4 ± 1.5 s), a result suggestive of little variation in 
chemical makeup of the mineral over adult life. In fact, as noted above, there was no T1 
versus age correlation. This finding is consistent with the relatively small variation in T1 
for a group of 16 tibia specimens from donors aged 27 to 97 years (96.7 ± 10.8 s 
measured at 7 T), in which T1-age correlation also was not found [27]. These 
observations indicate that relaxation measurements for bone 31P quantification may be 
unnecessary. In addition, group average [31P] quantified in the present study (6.40 ± 0.58 
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mol/L) is close to measurements ex vivo for a similar age range (6.74 ± 1.22 mol/L) [27] 
in which the experiment was free from interference of metabolites signal. For 
comparison, bone 31P was also quantified using relaxation times reported by Wu et al. (T1 
=18 s; T2* =160 µs) [42], yielding an average [31P] of 4.9 mol/L for the ten subjects, 
which is around 20% lower as predicted (Figure 4.5b). Bone 31P relaxation times 
published by Wu et al. were also used in an earlier work that investigated the feasibility 
of MRI-based bone matrix and mineral evaluation [84], and the average [31P] of 5.29 
mol/L found in the group of subjects for that study was likely an underestimation based 
on the relaxation data of the current study. 
The absence of an association with age of the 31P mineral density is unexpected but likely 
due to limited power with N = 10 subjects (despite the intentionally chosen relatively 
large age range). Interestingly, an earlier ex vivo study of mid-tibia specimens (N = 16) 
from donors aged 27 to 97 years showed the expected negative correlation of MR-
measured bone phosphorus density with age (R2 = 0.39, P < 0.05) [27]. However, when 
specimens of donors aged > 76 years are removed from their analysis, significance 
disappears (N = 11, R2 = 0.14, P = 0.26). Thus, it is likely that an age dependence of 
phosphorus density would be observed for a greater number of study subjects or by 
expanding the age range. 
Previously, Wu et al. performed both spectroscopic and image-based 31P T1 measurement 
of the bones in the wrist in vivo at 3 T. In their experiment, the steady-state 31P signal was 
acquired by progressively increasing TR (0.5, 1, 2, 3, and 5 s). A T1 range of 17 s to19 s 
was reported in two healthy subjects, which is about half the value found in the current 
work (average of 38.4 s in ten subjects). In contrast, ex vivo experiments by Seifert et al., 
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T1 of 31P in lamb tibia yielded 26 s and 66 s at 3 T and 7 T, respectively, whereas T1 of 
31P in the human tibia was found to be 96.7 s at 7 T [27, 41]. Because the T1 of human 
bone is longer than that of lamb bone at 7 T, it is reasonable to expect a qualitatively 
similar relation at 3 T. Therefore, our value of 38.4 s is likely to be more accurate (> 26 
s). There are several possible reasons for the disparity with our data: First, their 
spectroscopic measurement might have been affected by metabolite signal (Figure 4.5a), 
although the fraction of soft tissue is much less in the wrist than in the calf. Second, the 
relatively narrow range of TRs used, in particular the lack of a value close to equilibrium 
(two to three times T1), is well known to underestimate T1 with the progressive saturation 
technique, although an image-based measurement should be relatively immune to 
metabolite interference. 
4.6 Conclusion 
Quantification of bone 31P concentration is critically dependent on T1 and T2*, which 
were measured in vivo in the tibia at 3 T field strength. The results show the two 
parameters to vary insignificantly across the adult age range, therefore obviating the need 
for subject-specific measurements.  
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CHAPTER 5: IMPACT OF GRADIENT IMPERFECTIONS 
ON BONE WATER QUANTIFICATION WITH UTE 
5.1 Abstract 
Purpose: The impact of gradient imperfections (time delay and eddy current) on UTE 
images as well as UTE image-based bone water quantification was investigated at 3 T 
field strength.  
Methods: Simulation and phantom scans were performed to first study the effect of 
simple time delay on UTE image, and subsequently the effect of eddy current as well as 
the combined effect of eddy current and time delay. Healthy subjects were scanned to 
determine how is the bone water quantification influenced if the gradient errors are left 
uncorrected, only time delay is corrected and both delay and eddy current are corrected. 
In vivo experiments were also performed on two Siemens Trio systems to investigate the 
impact of such gradient imperfections on measurement agreement between scanners.  
Results: Gradient delays from -1.3 µs to 3.9 µs were measured using Rapid birdcage calf 
coil and 12-channel Siemens phased array head coil on two Siemens 3 T Trio scanners. 
Total water, bound water and pore water were up to 17%, 2.2% and 52% off from value 
derived from fully corrected images if no correction is performed, while up to 10.8%, 
2.2% and 32% off if only correcting for delay. Mean coefficient of variation between 
measurement from two Siemens Trio systems are 7.5%, 5.6% and 10.5% for total water, 
bound water and pore water without correction, 0.9%, 3.0% and 4.8% with delay 
correction only, and 1.3%, 2.7% and 7.8% with full trajectory correction.  
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Conclusion: k-Space trajectory mis-mapping due to gradient imperfections imposes 
spatially dependent artifact on UTE images, which compromise not only the bone water 
quantification accuracy but also undermines the inter-scanner measurement agreement if 
left unaccounted for.  
5.2 Introduction 
A number of studies in recent years have provided evidence that quantitative imaging of 
bone water with UTE and ZTE radial MRI is feasible [27, 29, 30]. Using similar 
technology, mineral phosphorus has been imaged by 31P MRI in bone specimens [27, 31, 
33] and also in vivo in humans [42, 44]. Collagen, the main component of bone matrix, is 
not directly visible by in vivo MRI due to its extremely short T2* (tens of microseconds), 
however, the protons on water molecules bound to the matrix (bound water) are 
detectable [39, 40, 53, 70] and scale linearly with matrix density. Pore space in cortical 
bone can also be indirectly evaluated by capturing the signal from water residing within 
the pores (pore water) [39, 40, 53, 70]. Further, since phosphorus is a primary constituent 
of bone mineral (non-stoichiometric calcium hydroxyapatite), quantitative 31P MRI can 
assess mineral density [42-44]. More recently, attempts have been made to quantify both 
bone water and bone mineral with an integrated in vivo protocol [84].  
One potential problem with short-TE MRI techniques is caused by the radial acquisition 
scheme, which is more susceptible to gradient imperfections than their Cartesian 
counterparts [100-106]. Hardware related time delays and eddy current-induced 
waveform distortions [107] result in k-space trajectories deviating from their prescribed 
paths. In Cartesian scanning, k-space trajectory deviations are consistent between phase 
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steps and will only lead to an undetectable linear phase shift in magnitude images. In 
radial sequences the k-space trajectory error varies with view angle, and this inconsistent 
k-space encoding may result in artifacts in the magnitude image. Furthermore, since each 
view passes through the central k-space region and determines overall image contrast, 
signal intensity measurements could be adversely affected yielding inaccurate values. 
Importantly, the gradient imperfections are scanner hardware dependent, but once 
quantified, the gradient trajectory errors can be accounted for in the reconstruction code.  
A number of techniques have been proposed to address this problem in UTE. Some are 
dedicated to the time delay correction only [106, 108], while others are designed to 
account for both the delay and waveform distortion [100, 106, 109-111]. Strategies 
correcting for both delay and eddy current generally fall into three categories. The first 
directly measures k-space trajectory along the three principal axes. Either a slice 
perpendicular to [100] or parallel with [109] the gradient direction is excited and the 
trajectory is tracked by following the phase evolution during the gradient ramp. The 
second category measures a finite portion of the readout gradient (including ramp) with a 
sequence designed to measure the gradient zeroth moment, from which the actual 
gradient waveform is extracted. The latter is subsequently used for UTE reconstruction 
[106]. A third category treats the gradient hardware as a system fully described by a 
gradient system transfer function (GSTF) or gradient impulse response function (GIRF), 
which can be measured either by a series of gradients of various shapes [110] or a single 
gradient waveform with broad frequency profile [111]. The actual gradient waveform, 
determined by operating the measured GSTF or GIRF on an ideal trapezoid shape, is 
applied to reconstruct the UTE image. However, to the best of the authors’ knowledge, 
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except for the work by Latta et al. comparing relative proton density in brain white matter 
from images with and without trajectory correction [112], there has been no systematic 
investigation of how UTE image and image-based quantification are affected by gradient 
imperfections, and particularly, how such errors impact inter-scanner agreement.  
This work is designed to evaluate the impact of gradient imperfections and consequential 
k-space trajectory mis-mapping on UTE image-based bone water quantification. Toward 
this end, simulation and phantom experiments were first performed to demonstrate image 
artifacts in the presence of different extents of k-space trajectory shift as well as the 
spatial dependence of the resulting artifacts. Bone water densities were then quantified 
and the results compared between human subject UTE images obtained without 
correction, with time delay correction, and both delay and eddy current correction. 
Finally, bone water densities obtained from two different MRI scanners were compared 
to evaluate the effect of image corrections on inter-scanner agreement. 
5.3 Materials and Methods 
5.3.1 Theory 
Ignoring relaxation, the signal collected in an MRI experiment can be represented as  
                                                               𝑠 𝒌 =  𝜌 𝒓  𝑒!!!!𝒌⋅𝒓 𝑑𝒓                                        [5.1] 
with 𝜌(𝒓) being the position-dependent spin density, and 𝒌 𝑡 =  !
!!
𝑮(𝑡), the time-
dependent spatial frequency vector. The argument of the exponential in Equation 5.1 
denotes the instantaneous phase 𝜑 𝑡 =  2𝜋 𝒌 𝑡  𝒓 of the k space signal at position 𝒓. 
After appropriate re-gridding (as required, for instance, in radial encoding) the image 
	
81	
typically is reconstructed as the inverse Fourier transform of the k-space (Equation 5.2):   
                                                               𝜌 𝒓 =  𝑠 𝒌  𝑒!!!𝒌⋅𝒓𝑑𝒌                                           [5.2] 
However, a realistic reconstruction requires accurate knowledge of the k-space trajectory, 
which is susceptible to inaccuracies in the gradient waveform 𝑮(𝑡). Due to hardware 
imperfections such as time delays and effects of eddy currents, the actual gradient 
𝑮′ 𝑡  ≠  𝑮(𝑡), i.e. the encoding gradient deviates from the prescribed waveform, and as 
a result, image quality is compromised by the mis-mapping of k-space data points.  
In the following sections we illustrate the problem with actual data and describe a method 
for gradient waveform correction in UTE imaging, with a particular focus on 
quantification of bone water. 
5.3.2 Gradient Delay, k-Space Trajectory Measurement and UTE Image Correction 
The k-space trajectory was measured with an extension of the mapping technique 
disclosed in abstract form [109]. The technique was originally proposed to map x- and y-
trajectories for 2D UTE, and was extended in this work for measurement along all three 
principal axes (Figure 5.1a). First, a 2D slice (5-mm thick) parallel to the targeted 
gradient direction was excited and phase-encoded along both directions, followed by a 
ramp-readout that is to be used for the UTE sequence. The two phase-encodings generate 
a series of 2D images, each corresponding to a single time-point along the readout 
gradient direction. Due to the presence of the gradient, each of these images presents a 
linear phase in the same direction, which progressively accumulates depending on the 
order of the image in this sequence (Figure 5.1b). From the phase 𝜑 𝑟, 𝑡 = 2𝜋 𝑘 𝑡  𝑟, 
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the slope of the straight line fitted to the linear pattern on each of these phase maps 
corresponds to the instantaneous k-space location, which is proportional to the zeroth 
gradient moment (Figure 5.1c). The true gradient waveform is simply the time derivative 
of the gradient moment curve (Figure 5.1d). This measured k-space trajectory embodies 
the effects of both time delay and eddy current-induced waveform distortions. To 
determine the time delay, the mid-point of the linear portion of the ramp on the measured 
gradient is compared to the mid-point of ramp on a nominally trapezoidal gradient 
(Figure 5.1e). The measured trajectory or gradient delay can thus be used for either full 
trajectory correction or delay only correction during image reconstruction. For full 
correction, trajectories along three principal axes are measured as described above, while 
the ones along oblique directions are represented as linear combinations of them. This is 
because the gradient system can be regarded as linear time invariant [113]. Image is 
subsequently generated by re-gridding reconstruction. For delay only correction, 
trajectories of principal axes are calculated from assumed trapezoid gradient waveform, 
but with measured delay incorporated. The oblique trajectories are obtained in the same 
way as in full trajectory correction. For the most accurate measurements of k-space 
trajectories and gradient delays, scan parameters such as FOV, dwell time and gradient 
ramp times should be matched to those of the actual UTE imaging sequence. 
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Figure 5.1 (a) Trajectory mapping sequence based on the technique proposed in [109]. (b) Phase 
maps acquired during ramp-up of the readout gradient. (c) Zeroth moment of the readout gradient 
(k-space trajectory) obtained by linear fitting the pattern of the phase maps along the gradient 
direction. (d) Time derivative of the gradient moment yields the true gradient waveform. (e) 
Gradient delay determined by comparing the mid-point of the measured gradient ramp with that 
of the ideal gradient (green line). (f) Actual gradient waveform deviates from nominal trapezoid 
due to eddy currents.  
5.3.3 Simulation Experiments 
Two sets of simulation experiments were performed. The first was to demonstrate the 
overall effect of various k-space shifts on the UTE image. Trajectories along the principal 
axes were calculated based on ideal trapezoidal gradient waveforms. Delays of -6 µs to 
+6 µs (hardware delays typically observed on clinical scanners [102, 108]) were 
introduced along the x-direction in 2-µs increments. Thereafter, the entire k-space was 
created as their linear combination. A more realistic scenario was simulated in the second 
experiment, where the actually measured delays and trajectories were used. Assumed 
scan parameters were: FOV = (250 mm)2, dwell time = 4 µs, ramp time = 240 µs; 158 
points along each FID were collected to reconstruct an image of matrix size 256x256. 
Images were reconstructed as described in [114]. Two types of phantoms were 
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considered: (1) a single large cylindrical object (110 mm diameter, resembling the 
standard Siemens cylinder phantom) placed at the FOV center, and (2) five smaller 
cylindrical objects (18 mm diameter) placed in a row along the x-axis, to investigate the 
spatial dependence of image artifacts. 
5.3.4 Phantom Imaging Experiments 
Phantom experiments were performed on a Siemens 3 T Trio system (Siemens Medical 
Solutions, Erlangen, Germany) using a 3D UTE sequence. The standard Siemens 
cylindrical phantom (3.75 g NiSO4·6H2O + 5 g NaCl per 1000 g H2O) was imaged with a 
birdcage calf coil (Rapid Biomedical, Rimpar, Germany) custom-made for 31P and 1H 
bone imaging of human subjects. In addition, five test-tubes of doped water (18 mm 
diameter, 20% H2O/80% D2O, doped with 27 mmol/L of McCl2 to achieve a H2O 
concentration of 11 mol/L, proton T1 = 4.5 ms, T2* = 327 µs) that served as 1H density 
calibration samples in an earlier in vivo bone water quantification study [84] were imaged 
with a wider vendor supplied 12-channel Siemens head coil to evaluate the spatial 
dependence of gradient-waveform related artifacts. Scan parameters matched those in the 
simulation experiments. Following data acquisition, images were reconstructed in three 
ways: 1) no correction, 2) correction for gradient delay only (delay correction), and 3) 
correction for both delay and eddy current (full trajectory correction). In addition, the 
same series of delays used in the simulations were intentionally introduced into the full 
trajectory corrected k-space data to demonstrate the influence of varying delays on actual 
experimental data. All resultant images were compared with simulations. 
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5.3.5 In Vivo Imaging Experiments 
To investigate the impact of gradient imperfections on bone water quantification, data 
acquired from a previous study in ten healthy subjects ranging in age from 29 to 65 years 
[84] were corrected with the measured gradient delay and k-space trajectories. The left 
mid-tibia of each subject was co-imaged with one 1H calibration sample as mentioned 
above. Total bone water and bound water were imaged with 1H UTE and 1H rapid 
inversion recovery-prepared UTE (IR-rUTE) respectively. Following reconstruction, the 
pixel intensities within the mid-tibia cortex were compared to that within the calibration 
sample, after accounting for the different relaxation times, to determine bone water 
concentration. For comparison, the different bone water pools were quantified from 
images without correction, with delay correction only and with full k-space trajectory 
correction. To investigate the impact of gradient imperfections on inter-scanner 
quantification agreement, the above procedure was performed once, on two Siemens Trio 
systems, on three separate subjects. The agreement in bone water densities obtained from 
the two scanners was compared with and without image correction. Both the phantom 
and in vivo images were reconstructed using the same algorithm used for the simulation. 
5.4 Results 
5.4.1 Effects of Simple k-Space Shift on UTE Image 
Simulated and experimentally acquired UTE images of a standard Siemens cylindrical 
phantom after introduction of gradient delays are shown in Figure 5.2. Most prominent 
are the edge effects, best seen in the profiles (b, d). Overall, there is close agreement 
between simulation and experiments except for some additional intensity modulation on 
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the experimentally acquired images (best visible on the profiles in Figures 5.2b and d), 
potentially caused by dielectric effects [115], as well as varying proximity to the coil 
elements. Intensity distortions worsen with increasing timing errors. Results from the five 
doped phantoms in Figure 5.3 also reveal the high spatial dependency of these artifacts 
— the farther away an object is located from the FOV center, the more severe the 
distortion. The slightly elevated intensities observed for off-center samples on the 
experimental images is likely due to greater coil sensitivity at these locations. 
 
Figure 5.2 (a) Simulated and (c) experimentally acquired UTE images of a standard Siemens 
phantom in the presence of gradient delays up to ±6 µs along x-direction (left-right) and their 
horizontal cross-sectional profiles (b, d). Compared to the profile of simulated images, the slight 
unevenness of the signal intensity is likely due to B1 inhomogeneity.  
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Figure 5.3 (a) Simulated and (c) experimentally acquired UTE images of five doped samples 
used for bone water calibration in the presence of different amounts of gradient delays along x-
direction (left-right) and (b, d) their respective horizontal cross-sectional profiles. Greater signal 
intensities observed for the outer samples of the sample array images are likely due to increasing 
coil sensitivity nearer to the head coil elements.  
To quantitatively determine the impact of such timing errors on image contrast, average 
intensities within the ROIs indicated in Figure 5.2a and 5.3a (red dashed circles) were 
compared among images with and without gradient delay for each phantom. Fractional 
differences in intensity are summarized in Table 5.1. Close agreement is observed 
between the simulation and experimental data for both large and small phantoms. 
Interestingly, although intensity increases with positive gradient delay and decreases with 
negative delay for the inner samples, a net signal loss always occurs for the outer samples 
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as a result of greater image distortions farther away from the FOV center. 
Table 5.1 Percent error in average intensity measured from ROIs in Figure 5.2a and Figure 5.3a 
as a function of gradient delay. 
Phantom Large Small 
Delay Simulation Experiment Simulation Experiment 
(µs)   1* 2 3 4 5 1 2 3 4 5 
-6 -20.2 -16.6 -24.0 -13.7 -9.5 -13.7 -28.7 -29.1 -15.0 -9.7 -16.2 -28.6 
-4 -13.8 -11.2 -12.0 -8.3 -6.5 -8.3 -15.6 -16.0 -9.2 -6.6 -10.3 -15.1 
-2 -7.0 -5.4 -3.6 -3.6 -3.6 -3.6 -5.4 -5.5 -3.9 -3.1 -4.4 -5.0 
0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
2 7.4 6.1 -2.4 2.4 3.6 2.4 0.6 0.0 2.4 3.1 2.9 -0.8 
4 15.0 11.8 -10.8 4.2 7.1 4.2 -5.4 -5.5 3.4 5.6 3.9 -7.1 
6 22.8 16.6 -25.7 3.6 10.7 3.6 -17.4 -15.6 3.4 7.7 3.9 -18.1 
* Sample number as indicated in Figure 5.3. 
 
5.4.2 Effects of Gradient Imperfections on Phantom UTE Images 
The gradient delays measured with the various combinations of coils and scanners used 
in this study are summarized in Table 5.2. Figure 5.4 illustrates the effects of eddy 
currents alone (after correcting for time delay) as well as the combined effect of delays 
and eddy currents (no correction at all) on UTE images via simulation and with actual 
experimental data. For the Siemens phantom, there appears to be some over-
compensation for delay correction only. For the calibration samples, on the other hand, 
delay correction achieves an intermediate result between no correction and full trajectory 
correction. 
Table 5.2 Gradient delays (µs) measured from two Siemens 3 T Trio scanners with two different 
coils. 
Scanner	 1	 2	
Coil	 Rapid	 Siemens	 Rapid	
X	Gradient	 2.2	 0	 2.8	
Y	Gradient	 1.0	 -1.3	 1.5	
Z	Gradient	 1.0	 -0.5	 3.9	
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Figure 5.4 (a, e) Simulated and (c, g) experimentally acquired UTE images of Siemens phantom 
and calibration samples. (b, d, f, h) Profiles (as indicated by the red dashed line) taken from 
images reconstructed with no correction, with gradient delay correction only, and with full 
trajectory correction are compared. 
5.4.3 Effects of Gradient Imperfections on In Vivo UTE Images 
Figure 5.5 displays the UTE and IR-rUTE images of a healthy subject reconstructed with 
and without gradient imperfection compensation. A cross-sectional profile through the 
calibration sample and the subcutaneous fat-muscle boundary is also plotted. As before, 
although the shapes of profiles are improved after accounting for gradient errors, a slight 
‘over-compensation’ was observed for delay only correction. Table 5.3 lists the percent 
errors in bone water derived from images with no correction and delay only correction 
relative to that derived from images with full correction. Figure 5.6 shows the percent 
variation in average pixel intensity within cortical bone and calibration sample with 
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respect to full trajectory correction. Figure 5.7 presents in vivo results obtained from two 
different MRI scanners. Inter-scanner agreement is improved with correction, as 
suggested by the lowered coefficient of variation. 
 
Figure 5.5 Axial view of 3D (a) UTE and (d) IR-rUTE images of the calf of a healthy subject 
acquired with dual-frequency calf coil. (b, c, e) Profiles as indicated in the cross-sectional images 
to illustrate effect of different reconstruction methods.  
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Table 5.3 Percent errors in bone water densities quantified from in vivo UTE images with no 
correction and delay only correction versus those with full trajectory correction.  
 Total Water Bound Water Pore Water 
Subject A B A B A B 
1 15.6 -10.4 0.0 -0.9 48.3 -30.0 
2 16.6 -10.8 0.0 -1.9 52.0 -32.0 
3 16.9 -10.1 1.7 -0.9 46.7 -28.3 
4 13.9 -7.3 -2.2 -2.2 38.6 -17.5 
5 15.7 -9.4 -1.0 0.0 34.8 -19.1 
6 16.4 -8.5 -1.0 0.0 40.0 -20.0 
7 16.2 -7.9 0.0 0.0 39.0 -19.5 
8 17.0 -9.1 0.9 -0.9 49.2 -27.1 
9 13.7 -7.7 2.1 -1.0 28.6 -15.5 
10 14.1 -8.6 0.0 -0.9 43.6 -25.5 
A: Uncorrected image relative to fully corrected image.  
B: Delay corrected image relative to fully corrected image.  
 
 
Figure 5.6 Percent difference in the average pixel intensity within cortical bone or calibration 
sample relative to the case of full trajectory correction.  
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Figure 5.7 Average inter-scanner coefficients of variation from three subjects chosen to test the 
impact of image correction on the inter-scanner agreement. 
5.5 Discussion 
Reconstructing non-Cartesian MRI data requires re-sampling (or re-gridding) collected 
data points onto a Cartesian grid before Fourier transformation. However, k-space value 
at each time point during readout might deviate from the nominal one due to the 
influences of time delays and eddy currents [105, 107, 113 116]. Compared to other 
radial MRI techniques collecting full echo, UTE (center-out) is particularly sensitive to 
eddy currents in that the k-space center, which dominates the image contrast, is directly 
impacted by them [107].  
As Figures 5.4 and 5.5 suggest, correcting for time delay alone does not fully remedy the 
problem. Eddy current effects must also be taken into account. Delay only correction 
achieved an outcome intermediate between no correction and full correction for small 
phantoms imaged with the Siemens head coil (Figure 5.4f and h), while appearing to 
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overcompensate for the large phantom imaged with the Rapid calf coil (Figure 5.4b and 
d) due to the residual effect of eddy current-induced gradient waveform distortion 
following delay correction, being equivalent to a negative time delay (Figure 5.1f). After 
accounting for the positive x-delay that accompanied the calf coil, it is this eddy current-
induced gradient distortion that remains. Conversely, the Siemens head coil did not have 
any delay to correct along the x-axis in the first place; the shape distortion observed in 
that direction (Figure 5.4h) is mainly due to the eddy current effects themselves. The 
increase in magnitude from profile with no correction to profile with delay only 
correction (Figure 5.4h) is due to correction of time delay existing in the other two 
directions (Table 5.2). 
Both time delay and eddy current are analogous to radially translating k-space data, 
which imparts a phase in that direction in the image domain — the farther away from the 
isocenter, the greater the phase accumulated. Therefore, the image artifact demonstrates 
the same spatial dependency (most clearly seen in Figures 5.2 and 5.3). This is of 
importance to quantification because the positioning of a subject and the calibration 
sample may vary from scan to scan. The measured signal intensity within the tibial cortex 
and the sample may be affected to different extents depending on their spatial locations 
within the FOV in the absence of a correction. In addition, the distorted intensity profile 
of an uncorrected image (Figure 5.3) may also make quantification sensitive to ROI 
placement. Accounting for these gradient imperfections is expected to improve not only 
intra-subject test-retest repeatability, but also augment the sensitivity to differentiate bone 
water concentrations between subjects.  
Furthermore, the gradient errors are not only direction-, but also hardware-dependent 
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(Table 5.2), and compensating for them does improve inter-scanner concordance (Figure 
5.7). Before correction, the CVs of TW and BW between two scanners (7.5% and 5.6%) 
are higher than those reported in an earlier study performed on a single scanner (3.5% 
and 2.6%) [84], but are reduced to 1.3% and 2.7% respectively following correction.  
Both Table 5.3 and Figure 5.7 indicate that the quantification of total water is more 
sensitive to k-space trajectory errors than bound water. The former is due to signal 
contamination from soft tissue in the absence of long-T2 suppression. In UTE images, the 
signal from soft tissues (such as muscle and bone marrow) may be interfering with the 
signal from cortical bone in the presence of gradient error (Figure 5.3). In IR-rUTE 
images, on the other hand, soft tissues are suppressed and signal contamination is 
therefore not an issue. As a result, the intensity change in cortical bone is more consistent 
with that of the calibration sample in IR-rUTE (Figure 5.6), leading to a less variable 
bound water quantification result (Table 5.3). By contrast, cortical bone had a drastically 
different change in intensity as compared to the calibration sample in UTE, and caused 
larger variations in total water quantification (Table 5.3).  
Several trajectory correction methods able to handle both time delay and eddy current 
[100, 105, 106, 109-111] have been proposed for UTE. The technique designed by 
Magland et al. [109] was chosen for the current study because it is simple to implement, 
it does not rely on any models where assumptions might have been made, and it directly 
measures the trajectory of the exact gradient waveform used for UTE imaging.  
Although the current study focuses on bone water quantification, the conclusions are 
equally applicable to evaluation of bone mineral. Both UTE and ZTE have previously 
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been explored as an alternative to CT for bone mineral interrogation via 31P MRI [27, 42, 
44, 84]. Similar artifacts were observed during our ZTE experiments (not shown here). 
Although neither gradient delay nor eddy current-induced gradient waveform distortion 
matter in ZTE, potential problems might be due to timing errors in other hardware 
components such as the frequency demodulation unit [103]. 
5.6 Conclusion 
In conclusion, the present study shows that gradient delay and eddy current-induced 
gradient waveform distortion compromise not only UTE image quality but, more 
importantly, bone water quantification. Correcting for these gradient system 
imperfections effectively alleviates image artifacts and substantially improves in vivo 
bone water quantification inter-scanner concordance. 
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CHAPTER 6: OSTEOPOROSIS TREATMENT STUDY  
6.1 Abstract  
Purpose: To test the ability of the previously described bone water and phosphorus MRI 
protocol to 1) differentiate osteoporotic patients from control subjects, and 2) reflect 
treatment outcomes in the patient cohort.  
Methods: Thirty post-menopausal women with osteoporosis and 30 age-, race- and BMI- 
matched healthy control subjects were planned to be recruited in an ongoing treatment 
study. All subjects will undergo the bone water and phosphorus MRI protocol described 
in Chapter 3 at baseline, 12 months and 24 months. Patients are given an intravenous 
zoledronic acid (zoledronate) infusion after the first and second imaging session. The 
surrogate markers for bone matrix density, porosity, and bone mineral density are derived 
from the acquired images and compared between the two groups.  
Results: Baseline data on nine subjects (seven controls, two patients) have been collected 
prior to submission of this writing. While the density of the surrogate marker for bone 
matrix, bound water, was found to be lower in the osteoporotic group, the density of the 
surrogate marker for porosity, pore water, was higher as predicted. The osteoporotic 
cohort also had a lower average phosphorus density as compared to the control group, 
suggesting a reduction in bone mineral content resulting from the disease. No obvious 
differences were observed in DMB between the two groups.  
Conclusion: Overall, baseline data obtained thus far suggest that this MRI protocol may 
be able to differentiate osteoporotic subjects from normal controls.  
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6.2 Introduction  
Patients with osteoporosis are often treated with bisphosphonates [1, 2], a group of 
medications that reduce bone resorption by inhibiting osteoclast cell activity [3]. 
Following anti-resorptive treatment, the density of bone matrix increases while the level 
of porosity decreases. Further, the decrease in turnover rate allows newly formed bone 
tissue additional time to undergo mineralization, thereby elevating bone mineral density. 
The purpose of the research summarized in this chapter is to investigate whether the bone 
water and phosphorus MRI protocol described in Chapter 3 can: 1) differentiate 
osteoporotic subjects from healthy controls; 2) track the treatment response in 
osteoporotic subjects. The ability to non-invasively detect changes in cortical porosity, 
and possibly DMB (both metrics have previously been shown to be altered in iliac bone 
biopsies [4, 5]), may allow for improved monitoring of treatment effects and provide 
further insight into the mechanism by which bisphosphonates decrease fracture risk. 
Toward this end, a group of osteoporotic patients and healthy controls are being recruited 
to participate in a 24-month clinical study.  
6.3 Materials and Methods  
The study design is illustrated in Figure 6.1. A cohort of 60 post-menopausal women, 30 
osteoporotic patients and 30 healthy controls, are being recruited. The primary source of 
patients is Penn Medicine’s Bone Center. Osteoporotic women are also recruited from 
primary care, obstetrics and gynecology, and endocrinology clinics at Penn Medicine, all 
of which routinely screen and treat patients with osteoporosis. Control subjects are 
recruited through localized postings of rack cards and flyers and email  
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blasts to the University of Pennsylvania and Penn Medicine community, methods that 
have previously proven effective. The patient group includes post-menopausal women, 
ages 50–75 years with a BMD T-score ≤ -2.5 at either the spine, total hip or femoral 
neck, as determined by DXA, who have not had a menstrual period for at least two years. 
The control group includes women without osteoporosis who are age-, race- and BMI-
matched to subjects in the osteoporotic group. Exclusion criteria are: (a) current or prior 
use of medications known to affect bone (bisphosphonates, calcitonin, denosumab, 
teriparatide, estrogen, estrogen agonists/antagonists, thiazolidinediones, glucocorticoids, 
phenobarbital, phenytoin); (b) diseases known to affect bone (hyperparathyroidism, 
hyperthyroidism, diabetes, inflammatory bowel disease, liver or kidney disease), severe 
cardiac disease, current alcohol or drug abuse, 25-OH vitamin D level less than 20 ng/ml; 
(c) contraindications to bisphosphonates; (d) contraindications for MRI. All subjects 
undergo the bone water and phosphorus protocol described in Section 3.3.2 at baseline, 
12 months and 24 months. One intravenous infusion of zoledronic acid (a type of 
bisphosphonate medicine, also know as zoledronate [6]) is administered to the 
osteoporotic group immediately after the first and second MRI exam, while no medical 
intervention is performed in the control group. MRI-based surrogate markers are derived 
and their values compared between the two groups at each time point, and longitudinally 
within each group via ANOVA.  
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Figure 6.1 Illustration of the clinical study design. A total of 60 post-menopausal women are 
being recruited, 30 osteoporotic patients and 30 healthy controls. The osteoporotic group receives 
a two-year zoledronate treatment (one annual intravenous infusion) while the control group does 
not get any intervention. Both cohorts undergo the bone water and phosphorus MRI protocol 
described in previous chapters at three time points: baseline, 12 months and 24 months.  
6.4 Baseline Results Obtained So Far  
Baseline data for nine subjects (two osteoporotic patients, seven control subjects) have 
been collected at the time of this writing. Representative total water, bound water, and 
phosphorus images are shown in Figure 6.2. Figure 6.3 compares surrogate marker color 
maps of a healthy control with those of a patient. The DXA-reported BMD, T-score and 
MR image-derived surrogate markers of all nine subjects are summarized in Table 6.1. 
DMB is represented as the ratio between [31P] and [BW], with [31P] being a volumetric 
quantity as described in Chapter 3 (including the phosphorus signal within the entire 
bone region).  
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Figure 6.2 Bone water and phosphorus images of two healthy control subjects and two 
osteoporotic patients. Compared with healthy controls, osteoporotic subjects have thinner cortical 
bone, higher total water signal and lower phosphorus signal.  
 
Figure 6.3 Color maps of surrogate markers for a healthy control and an osteoporotic patient.  
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Table 6.1 DXA-reported BMD, T-score and MRI-derived surrogate marker densities of healthy 
and osteoporotic subjects recruited to date.  
Controls 
 T-Score BMD (g/cm2) 
Bone Water 
(mol/L) 
31P 
(mol/L) 
31P/BW 
Age Femoral Neck 
Total 
Hip 
Total 
Lumbar 
Femoral 
Neck 
Total 
Hip 
Total 
Lumbar TW BW PW  
 
55 -0.2 -0.3 0.1 0.831 0.905 1.055 20.6 10.6 10.0 5.2 0.49 
58 -2.0 -1.0 -0.9 0.623 0.824 0.951 21.4 9.2 12.2 5.5 0.60 
61 -1.7 -1.0 -1.1 0.665 0.824 0.921 22.5 10.3 12.4 5.5 0.53 
62 0.1 0.5 0.2 0.864 0.997 1.065 19.6 11.2 8.2 6.6 0.59 
65 -0.7 -0.7 1.2 0.774 0.861 1.175 18.6 10.1 8.3 5.9 0.58 
67 -1.2 -0.6 -1.3 0.713 0.872 0.908 17.4 9.8 7.3 5.6 0.57 
68 -1.5 -0.3 -1.8 0.678 0.906 0.844 19.4 9.9 9.4 5.9 0.60 
Mean -1.0 -0.5 -0.5 0.735 0.884 0.988 19.9 10.2 9.7 5.7 0.57 
Patients 
 T-Score BMD (g/cm2) 
Bone Water 
(mol/L) 
31P 
(mol/L) 
31P/BW 
Age Femoral Neck 
Total 
Hip 
Total 
Lumbar 
Femoral 
Neck 
Total 
Hip 
Total 
Lumbar TW BW PW  
 
66 -2.4 -2.3 -2.6 0.586 0.666 0.761 26.3 8.9 17.4 4.7 0.53 
69 -3.0 -2.1 -1.2 0.514 0.690 0.917 22.6 8.1 14.9 5.0 0.62 
Mean -2.7 -2.2 -1.9 0.550 0.678 0.839 24.5 8.5 16.1 4.9 0.58 
	
6.5 Discussion  
Several observations are expected throughout the course of this study. First, due to loss of 
bone tissue and its accompanying increase in porosity, bound water and phosphorus 
density measured from osteoporotic subjects should be lower, while pore water density 
should be higher than in control subjects at baseline. Second, women with osteoporosis 
should have a lower DMB than their non-osteoporotic counterparts due to a shorter 
period of secondary mineralization from the fast turnover rate [4, 7] at the baseline. 
Third, the aforementioned differences between the two groups are expected to reduce 
following administration of zoledronate.  
As suggested by the data in Figure 6.2, patients are characterized with thinner cortical 
bone, a higher total water signal and a lower phosphorus signal. These observations are 
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confirmed in the color maps in Figure 6.3. Notably, bound water density is lower while 
pore water is higher in patients as compared to controls, suggesting that the elevated total 
water signal seen in the patients in Figure 6.2 is mainly due to increased porosity. 
Quantification results in Table 6.1 also indicate that osteoporotic patients present an 
increased average porosity level as compared to their healthy counterparts. The surrogate 
of bone mineral, phosphorus density, also appears lower in the osteoporotic subjects. The 
overall trend of the baseline data acquired to date is consistent with expectations. 
Although additional data are needed to establish the statistical significance of the baseline 
results and to evaluate the effectiveness of the proposed protocol in monitoring treatment 
response, the present preliminary work provides confidence in achieving these goals.  
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CHAPTER 7: CONCLUSIONS AND FUTURE WORK  
7.1 Conclusions  
The main results of this dissertation are summarized as follows:  
7.1.1 Feasibility of MRI-Based Bone Matrix and Mineral Quantification In Vivo  
In Chapter 3, the feasibility of quantifying bone water, the surrogate marker for bone 
matrix, and 31P, the surrogate marker for bone mineral content, with solid-state MRI in a 
single session (within one hour) in vivo was investigated. The average concentrations for 
TW, BW and PW were 13.99 ± 1.26, 10.39 ± 0.80 and 3.34 ± 1.41 mol/L respectively, 
while the 31P concentration was 5.29 ± 1.15 mol/L in a group of ten healthy subjects 
ranging in age from 29 to 65. These quantities were comparable to the ex vivo results 
published earlier with test-retest CV of 3.5%, 2.6 %, 6.5 % and 5.7 % for TW, BW, PW 
and 31P respectively. The negative correlations between PW density and HR-pQCT 
derived BMD (p < 0.05), PI and 31P (p < 0.05), and the positive correlations between TW 
and PW (R = 0.81, p < 0.005), between BMC estimated from 31P MRI and HR-pQCT (p 
< 0.0001), further enhanced the credibility of this study. The findings in this chapter 
demonstrate the potential of MRI as a clinical tool to evaluate the bone health.  
7.1.2 In Vivo Bone 31P Relaxation Time Measurements and Their Implications in 
Mineral Quantification  
In Chapter 4, a spectrum-based technique proposed to measure bone 31P relaxation times 
in vivo was initially evaluated via simulation and then in an ex vivo experiment, and 
subsequently applied to ten healthy subjects. Although subject’s age range spanned 50 
years (26 to 76), the bone 31P relaxation times were relatively tightly distributed: T1 = 
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38.4 ± 1.5 s, T2* = 178.3 ± 9.0 μs. Bone 31P density was estimated to be 6.40 ± 0.58 
mol/L for the same group of subjects using measured relaxation times. The average CV’s 
were 1.5%, 2.6% and 4.4% for 31P density, T1 and T2*, respectively. Based on these 
observations, individually measuring relaxation properties for healthy subjects may not 
be necessary.  
7.1.3 The Importance of Gradient Error Correction on UTE-Based Bone Water 
Quantification  
In Chapter 5, both simulation and phantom experiments demonstrated that gradient 
imperfections (time delay and eddy current-induced waveform distortion) lead to errors 
in k-space trajectory and spatially dependent object distortions in reconstructed UTE 
images. Quantitative analyses further revealed that gradient errors undermine not only the 
image-based quantification but also the measurement agreement between different 
scanners. The work in this chapter emphasizes the necessity of correcting gradient errors 
for quantitative studies involving UTE imaging.  
7.2 Future Work  
Based on the results presented in this dissertation, the following issues are worthy of 
further investigation:  
7.2.1 Influence of Hardware Imperfections on 31P ZTE-Based Bone Mineral 
Quantification  
Chapter 5 demonstrated that imperfections in the encoding gradient substantially 
impacted both UTE image quality and image-based bone water quantification. Although 
not discussed here, similar artifacts were observed by the author in ZTE experiments. 
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Since encoding gradients are already fully ramped up prior to excitation in ZTE, k-space 
mis-mapping should not stem from gradient delay or waveform distortion as in UTE. 
Rather, mis-mapping is more likely due to the relative timing error between the RF pulse 
and data acquisition (ADC). It would be of interest to explore the effects of such 
hardware timing errors on 31P ZTE-based bone mineral quantification.  
7.2.2 The Ongoing Clinical Study  
Only a small number of subjects had undergone a baseline MRI exam at the time of this 
writing (Chapter 6), which limited the statistical power of the data. Statistically 
significant differences between average bone water and phosphorus quantities at baseline 
should be observed between patients and healthy controls with the addition of more study 
subjects. Further, as zoledronate has been demonstrated to increase bone volume in 
ovariectomized animal models (simulating estrogen depletion-induced osteoporosis 
during post-menopause) [9, 10] and to increase BMD in osteoporotic patients [6, 11, 12], 
a treatment dependent reduction in surrogate marker differences between the two groups 
is expected at the second and third time points.  
7.2.3 Imaging Protocol Acceleration with Interleaved 1H/31P Acquisition  
The proposed in vivo bone water and phosphorus imaging protocol consists of one 1H 
UTE sequence for imaging of total water (8.3 min), one 1H IR-rUTE sequence for 
imaging of bound water (5.8 min) and one 31P ZTE for imaging of bone phosphorus (22.5 
min). For the spoiled steady-state gradient sequence (which the 31P ZTE is analogous to), 
SNR time efficiency is relatively constant for a wide range of TRs as long as the 
corresponding Ernst angle is used. The particular TR and Ernst angle combination used in 
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our 31P ZTE application results in less than 1% of the entire TR being spent on encoding 
and acquiring data while the remaining 99% is idle time. If this idle time within the 31P 
sequence could be utilized for 1H acquisition, the entire protocol could be accelerated by 
almost 50%. As illustrated in Figure 7.1, the entire 31P ZTE can potentially be divided 
into two halves. The first half is interleaved with multiple TRs of 1H dual-echo UTE 
(Figure 7.1a) while the second half is interleaved with one TR of 1H IR-rUTE (Figure 
7.1b). Since 1H and 31P sequences operate at very different frequencies (due to their 
distinct gyromagnetic ratio), they should not interfere with each other and therefore 
maintain their respective steady-state.   
 
Figure 7.1 Schematic plot of interleaved 1H/31P sequence: a) 31P ZTE interleaved with 1H dual- 
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eco UTE; b) 31P ZTE interleaved with 1H IR-rUTE.  
7.2.4 Potential to Differentiate Bone Diseases  
Routinely used x-ray based bone examination techniques have certain limitations. For 
instance, DXA makes a diagnosis based on 2D projection and is consequently prone to 
bias from bone size and shape. Further, its reported BMD does not reflect a true 
mineralization level as the modality cannot distinguish between bone tissue and pore 
space. Nor are 3D clinical techniques, such as pQCT, able to provide true BMD due to 
their limited spatial resolution. Therefore, these exams cannot definitively differentiate 
bone diseases such as osteoporosis, characterized by a loss of bone volume with the 
remaining tissue properly mineralized, or osteomalacia, a condition distinguished by poor 
mineralization and intact total bone volume. With the ability to separately interrogate 
bone’s organic and mineral phase, the proposed protocol may have the potential to 
distinguish these two conditions from each other. Because osteoporosis and osteomalacia 
have distinct underlying mechanisms and require different treatment plans, a non-
invasive efficient method of differentiation would be of considerable clinical interest. 
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